Patient risk assessment based on data from multiple sources in a healthcare facility

Abstract

Apparatus for assessing medical risks of a patient includes an analytics engine and equipment that provides data to the analytics engine. The equipment includes a patient support apparatus such as a patient bed, a nurse call computer, a physiological monitor, a patient lift, a locating computer of a locating system, and an incontinence detection pad. The analytics engine analyzes the data from the equipment to determine a sepsis risk score, a falls risk score, and a pressure injury score. The apparatus further include displays that are communicatively coupled to the analytics engine and that display the sepsis, falls, and pressure injury risk scores. The displays include a status board display located at a master nurse station, an in-room display provided by a room station of a nurse call system, an electronic medical records (EMR) display of an EMR computer, and a mobile device display of a mobile device of a caregiver assigned to the patient.

Claims

1. A system for use in a healthcare facility, the system comprising an analytics engine, a plurality of equipment providing data to the analytics engine, the data pertaining to a patient in the healthcare facility, the plurality of equipment including at least one of the following: a patient support apparatus, a nurse call computer, a physiological monitor, a patient lift, a locating computer of a locating system, or an incontinence detection pad, wherein the analytics engine analyzes the data from the plurality of equipment to determine in substantially real time each of the following: a first score relating to a risk of the patient developing sepsis, a second score relating to a risk of the patient falling, and a third score relating to a risk of the patient developing a pressure injury, a computer coupled to the analytics engine and coordinating a caregiver rounding interval at which at least one caregiver assigned to the patient is required to check in on the patient, wherein when the analytics engine determines the first score, in response to the first score increasing from a first value to a second value, the analytics engine automatically activates an infusion pump for the delivery of IV antibiotics and the computer automatically decreases the caregiver rounding interval; when the analytics engine determines the second score, in response to the second score increasing from a first value to a second value, the analytics engine automatically activates a bed exit or patient position monitoring system and the computer automatically decreases the caregiver rounding interval; and when the analytics engine determines the third score, in response to the third score increasing from a first value to a second value, the analytics engine automatically activates an alternating pressure function of a mattress and the computer automatically decreases the caregiver rounding interval; and wherein the computer automatically increases the caregiver rounding interval in response to the at least one of the first, second, or third scores decreasing from the second value to the first value, and a mobile device of a caregiver assigned to the patient and configured to receive wireless communications initiated by the analytics engine, the mobile device being configured to generate a screen on a display of the mobile device, the screen including: a first window having a scoring section that includes a modified early warning score (MEWS) calculated by the analytics engine and one or more vital signs that contribute to the calculation of the MEWS score; a second window indicating the risk of the patient developing sepsis by displaying the first score calculated by the analytics engine; and a third window indicating the risk of the patient falling by displaying the second score calculated by the analytics engine, wherein the screen further includes respective arrow icons that appear adjacent the MEWS, the first score, and the second score to indicate whether the MEWS, the first score, and the second score, respectively, have increased or decreased from a prior reading.

2. The system of claim 1, further comprising a plurality of additional displays communicatively coupled to the analytics engine and operable to display the first, second, and third scores, the plurality of displays comprising at least two of the following: a status board display located at a master nurse station, an in-room display provided by a room station of a nurse call system, and an electronic medical records (EMR) display of an EMR computer.

3. The system of claim 1, wherein the plurality of equipment includes at least three of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.

4. The system of claim 1, wherein the plurality of equipment includes at least four of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.

5. The system of claim 1, wherein the plurality of equipment includes at least five of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.

6. The system of claim 1, wherein the plurality of equipment includes all six of the following: the patient support apparatus, the nurse call computer, the physiological monitor, the patient lift, the locating computer, and the incontinence detection pad.

7. The system of claim 1, wherein each of the first, second, and third scores is normalized by the analytics engine so as to have a minimum value and a maximum value that is common to each of the other first, second, and third scores.

8. The system of claim 7, wherein the minimum value is 0 for each of the first, second, and third scores.

9. The system of claim 7, wherein the minimum value is 1 for each of the first, second, and third scores.

10. The system of claim 7, wherein the maximum value is 5 for each of the first, second, and third scores.

11. The system of claim 1, wherein the analytics engine also receives additional data from an international pressure ulcer prevalence (IPUP) survey for the patient and analyzes the additional data in connection with determining at least one of the first, second, and third scores.

12. The system of claim 1, wherein the analytics engine communicates at least two of the first, second, and third scores to at least one piece of equipment of the plurality of equipment.

13. The system of claim 1, wherein the at least one piece of equipment of the plurality of equipment includes a device display and wherein steps for lowering at least one of the first, second, and third scores is displayed on the device display.

14. The system of claim 1, wherein the plurality of equipment includes the patient support apparatus and wherein data from the patient support apparatus includes at least one patient vital sign sensed by at least one vital sign sensor integrated into the patient support apparatus.

15. The system of claim 14, wherein the at least one patient vital sign sensed by the at least one vital sign sensor includes heart rate or respiration rate.

16. The system of claim 14, wherein data from the patient support apparatus further includes patient weight.

17. The system of claim 1, wherein the plurality of equipment includes the patient support apparatus and wherein data from the patient support apparatus includes patient weight and a position of the patient on the patient support apparatus.

18. The system of claim 17, wherein data from the patient support apparatus further includes data indicative of an amount of motion by the patient while supported on the patient support apparatus.

19. The system of claim 1, wherein the plurality of equipment includes the physiological monitor and wherein data from the physiological monitor includes one or more of the following: heart rate data, electrocardiograph (EKG) data, respiration rate data, patient temperature data, pulse oximetry data, and blood pressure data.

20. The system of claim 1, wherein the first score is at or near a maximum value if the following criteria exist: i) the patient's temperature is greater than about 38.3° Celsius (C) (about 101° Fahrenheit (F)) or less than about 35.6° C. (about 96° F.), ii) the patient's heart rate is greater than 90 beats per minute; and iii) the patient's respiration rate is greater than 20 respirations per minute.

21. The system of claim 1, wherein the analytics engine initiates a message to the mobile device of the caregiver assigned to the patient if the first, second, or third score increases from a previous value.

22. The system of claim 1, wherein the analytics engine initiates a message to the mobile device of the caregiver assigned to the patient if the first, second, or third score reaches a threshold value.

23. The system of claim 1, wherein the analytics engine also receives additional data relating to at least one wound of the patient and analyzes the additional data in connection with determining at least one of the first, second, and third scores.

24. The system of claim 23, wherein the additional data relating to the at least one wound includes an image of the at least one wound.

25. The system of claim 1, wherein the plurality of equipment includes the patient support apparatus and wherein the patient support apparatus comprises a patient bed or a stretcher.

26. The system of claim 1, wherein the analytics engine also receives additional data relating to at least one of the following: fluid input and output, cardiac output, comorbidities, and bloodwork, and wherein the analytics engine analyzes the additional data in connection with determining at least one of the first, second, and third scores.

27. The system of claim 1, wherein the plurality of equipment includes the physiological monitor and wherein the physiological monitor comprises at least one of the following: a wireless patch sensor attached to the patient, an ambulatory cardiac monitor, an EKG, a respiration rate monitor, a blood pressure monitor, a pulse oximeter, and a thermometer.

28. The system of claim 1, wherein the plurality of equipment further comprises a chair monitor to monitor patient movement while the patient is seated on a chair.

29. The system of claim 1, wherein the plurality of equipment further comprises a toilet monitor to monitor patient movement while the patient is seated on a toilet.

30. The system of claim 1, wherein the analytics engine is configured to receive patient demographics data of the patient including at least one of age, race, and weight; wherein the analytics engine is configured to receive comorbidity data of the patient including data indicating that the patient has at least one of the following medical conditions: acquired immunodeficiency syndrome (AIDS), anemia, chronic congestive heart failure, asthma, cancer, chronic obstructive pulmonary disease (COPD), coronary artery disease, cystic fibrosis, dementia, emphysema, alcohol or drug abuse, stroke, pulmonary emboli, a history of sepsis, type 1 diabetes, morbid obesity, neuromuscular disease, prior intubation, scoliosis, smoker, delirium, asplenic, bone marrow transplant, cirrhosis, dialysis, diverticulosis, heart valve disorders, inflammatory bowel disease, joint replacement, leukopenia, malignancy, neoplasm, organ transplant, peripheral vascular disease, renal disease, pressure injury, recent abortion, recent childbirth, seizures, sickle cell anemia, or terminal illness; wherein the plurality of equipment includes the physiological monitor and wherein the analytics engine is configured to receive physiological data measured by the physiological monitor having at least one sensor coupled to, or in communication with, the patient, the physiological data being dynamic and changing over time while the patient is being monitored by the physiological monitor; and wherein the analytics engine is configured to calculate a risk score of the patient in substantially real time based on the patient demographics data, the comorbidity data, and the physiological data.

31. The system of claim 1, wherein the analytics engine is configured to: receive dynamic clinical variables and vital signs information of the patient, use the vital signs information to develop prior vital signs patterns and current vital signs patterns, compare the prior vital signs patterns with the current vital signs patterns, receive one or more of the following: static variables of the patient, subjective complaints of the patient, prior healthcare utilization patterns of the patient, or social determinants of health data of the patient, and use the dynamic clinical variables, the vital signs information, the results of the comparison of the prior vital signs patterns with the current vital signs patterns, and the one or more of the static variables, the subjective complaints, the healthcare utilization patterns, or the social determinants of health data in an algorithm to detect or predict that the patient has sepsis or is likely to develop sepsis.

32. The system of claim 1, wherein a risk determination is made or one or more of the first, second, or third scores is calculated based on one or more of the data elements listed in Table 11.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

(1) The detailed description particularly refers to the accompanying figures, in which:

(2) FIG. 1 is a diagrammatic view of a system showing bed data, incontinence detection system data, vital signs data, and data from an international pressure ulcer prevalence (IPUP) survey being provided to an analytics engine and showing the analytics engine initiating real-time clinical communication to caregivers based on an analysis of the received data;

(3) FIG. 2 is a diagrammatic view of a system, similar to FIG. 1, showing in a top row, from left to right, a patient supported on a patient bed, an analytics engine (labeled as “DSN platform” in FIG. 2) receiving data from the patient bed, the analytics engine communicating risk assessment messages back to the patient bed and to a vital signs monitor, and showing in a second row, from right to left, the patient bed monitoring patient position, and a caregiver taking a picture of a pressure injury of the patient;

(4) FIG. 3 is a diagrammatic view of a system, similar to FIGS. 1 and 2, showing a router located in a center of the view receiving data from a plurality of data source equipment situated to the left of the router and communicating to a plurality of data receiving equipment to the right of the router, the data source equipment including a patient bed, a graphical room station of a nurse call system, a vital signs monitor, a patient lift, a locating system, and an incontinence detection system, and the data receiving equipment including a status board, an in-room display, an analytics engine, an electronic medical records (EMR) or health information systems (HIS) server, and a set of mobile devices;

(5) FIGS. 4A-4C form a flow chart showing an example of a patient's journey through an emergency department (ED), an intensive care unit (ICU) and a medical/surgical (MED/SURG) unit, and then home or to a long term care (LTC) facility and showing locations within the patient flow at which the analytics engine operates to determine the patient's risk of having or developing sepsis;

(6) FIGS. 5A and 5B form a flow chart showing an example of a patient's admission and stay at a healthcare facility including use of equipment in the patient's room to move the patient to a chair or into a bathroom, and showing locations within the patient flow at which the analytics engine operates to make a risk assessment for the patient;

(7) FIG. 6 is a diagrammatic view of an alternative system, similar to FIG. 3, showing hospital on-premises equipment at the left side of the page including in-room devices, a device gateway, and a status board; cloud devices at a center of the page including an enterprise gateway (HL7), a clinical data repository, a risk engine, and an analytics artificial intelligence (AI) platform; and additional on-premises equipment at the right side of the page including a mobile device and 3.sup.rd party solutions including EMR, ADT, and Labs servers;

(8) FIG. 7 is a screen shot example of a Patient screen of a mobile application of the mobile devices of FIGS. 3 and 6, showing the Patient screen including a list of patient names assigned to a caregiver that carries the mobile device, a room number to the left of each patient name, and risk scores including, when applicable, a systemic inflammatory response syndrome (SIRS) value and a modified early warning score (MEWS) value, beneath each of the patient names;

(9) FIG. 8 is a screen shot example of a Risk Details screen that, beneath the patient's name, includes a MEWS window having additional information pertaining to the MEWS value, a Sepsis-Related Organ Failure Assessment (SOFA) window having additional information pertaining to a SOFA score, and a MORSE window having additional information pertaining to a MORSE Fall Scale (MFS) value, and that also includes a pair of Risk Contributors windows including a respiratory distress window listing factors contributing to a risk that the patient will experience respiratory distress and a sepsis window listing factors contributing to the patient's risk of developing sepsis;

(10) FIG. 9 is a screen shot example of an alternative Risk Details screen that, beneath the patient's name, includes MEWS, SIRS, and SOFA windows having sub-scores information, where applicable, that contribute to the overall score, and that also includes the pair of Risk Contributors windows similar to those of FIG. 8; and

(11) FIG. 10 is a screen shot example of a MEWS Details screen that provides greater details relating to the MEWS value including showing which vital signs or other information corresponds with each of the sub-score values that contribute to the overall MEWS value, the MEWS Details screen appearing on the caregiver's mobile device in response to selection of the MEWS window on the Risk Details screen of FIG. 8 or 9.

DETAILED DESCRIPTION

(12) An apparatus or system 10 includes sources 12 of patient data that communicate with an analytics engine 20 in substantially real time for real-time clinical data aggregation as shown diagrammatically in FIG. 1. In the illustrative example of FIG. 1, the sources 12 of patient data include a patient bed 14, an incontinence detection system 16, a vital signs monitor 18, and an international pressure ulcer prevalence (IPUP) survey 22. Bed data from patient bed 14 includes, for example, data indicating whether bed siderails are up or down, data indicating whether caster brakes are set, data indicating an angle at which a head section of a mattress support deck is elevated, data indicating whether or not an upper frame of the patient bed 14 is at its lowest height relative to a base frame of the bed 14, and other bed data as is known to those skilled in the art. See U.S. Patent Application Publication No. 2012/0316892 A1, which is hereby incorporated by reference herein, particularly with regard to Table 1, for additional examples of bed data.

(13) Some embodiments of patient bed 14 have a weigh scale system that senses patient weight and that, in some embodiments, also monitors a position of a patient while supported on bed 14. See, for example, U.S. Pat. No. 7,253,366 which is hereby incorporated by reference herein in its entirety to the extent not inconsistent with the present disclosure which shall control as to any inconsistencies. Some embodiments of patient bed 14 also include integrated vital signs sensors to sense the patient's heart rate or respiration rate. See, for example, U.S. Patent Application Publication No. 2018/0184984 A1, which is hereby incorporated by reference herein in its entirety to the extent not inconsistent with the present disclosure which shall control as to any inconsistencies. Thus, patient weight data, patient position data, and vital signs data sensed by one or more on-bed sensors is also among the data that bed 14 transmits to analytics engine 20 in some embodiments.

(14) In some embodiments, the incontinence detection system 16 is the WATCHCARE™ incontinence detection system available from Hill-Rom Company, Inc. Additional details of suitable incontinence detection systems 16 can be found in U.S. Patent Application Publication Nos. 2017/0065464 A1; 2017/0246063 A1; 2018/0021184 A1; 2018/0325744 A1 and 2019/0060137 A1, each of which is hereby incorporated herein by reference in its entirety to the extent not inconsistent with the present disclosure which shall control as to any inconsistencies. The incontinence detection system 16 communicates to analytics engine 20 data indicating whether an incontinence detection pad of system 16 that is placed underneath the patient is wet or dry.

(15) In some embodiments, the incontinence detection pad of system 16 has a passive RFID tag that is activated by energy transmitted from one or more antennae that are situated beneath a mattress of patient bed 14 and on top of a mattress support deck of patient bed 14. Backscattered data from the passive RFID tag is read by one or more of these same antennae. A reader is provided to control which antenna of a plurality of antennae is the transmit antenna at any given instance, with the remaining antennae being receive antennae. The backscattered data received by the reader via the receive antennae is communicated to the analytics engine 20 via the reader, such as via a wireless transmission from the reader to a wireless access point of an Ethernet of the healthcare facility, or via the circuitry of bed 14 in those embodiments in which the reader is communicatively coupled to the bed circuitry such as via a wired connection.

(16) Vital signs monitors 18 include, for example, electrocardiographs (ECG's or EKG's), electroencephalographs (EEG's), heart rate monitors, respiration rate monitors, temperature monitors, pulse oximeters, blood pressure monitors, and the like. Monitors 18 are standalone devices in some embodiments that are separate from bed 14. In some embodiments, at least one of the vital sign monitors 18 is the CONNEX® Spot Monitor available from Welch Allyn, Inc. of Skaneateles Falls, N.Y. As noted above, bed 14 includes its own integrated vital signs sensors in some embodiments. Thus, vital signs data provided to analytics engine 20 from vital signs monitors 18 or from bed 14 includes any one or more of the following: heart rate data, respiration rate data, temperature data, pulse oximetry data, blood pressure data, and the like.

(17) The IPUP survey 22 includes information such as the following: 1) unit in which the patient is located, 2) patient age, 3) sex of the patient, 4) whether the patient is incontinent, 5) whether the patient has incontinence associated dermatitis, 6) whether an incontinence detection pad of system 16 is being used, 7) length of the patient's stay since admission to the healthcare facility, 8) the type of surface (e.g., mattress) on the patient's bed 14, 9) number of layers of linen (including diapers and briefs) between the patient and the support surface, 10) the type of linen used, 11) the patient's mobility status (e.g., completely immobile, makes small weight shifts but unable to turn to side, turns to side on own but requires help to stand, or independent), 12) observed position (e.g., on back, on side, prone, chair, or standing), 13) whether a patient lift has been used during the patient's stay, 14) whether the patient's heels are elevated when in bed, 15) patient's height (or length for infants), 16) patient's weight, 17) neonatal weight (in grams), 18) time spent in the emergency room (ER), 19) time spent in the operating room (OR), 20) whether the patient's skin was assessed within 24 hours of admission, 21) whether a pressure injury assessment was documented within 24 hours of admission, 22) the risk methodology used at admission, 23) the risk score(s) determined during admission, 24) the most recent or current risk methodology used, 25) the most recent or current risk score(s), 26) documentation of last risk assessment (e.g., time since last pressure ulcer/injury risk assessment prior to the current survey and whether the last risk assessment was documented), 27) whether the patient was determined to be at risk for pressure injuries, 28) whether pressure injury prevention protocols have been in effect for the last 24 hours for an at risk patient, 29) whether a skin assessment was documented within the past 24 hours, 30) whether a pressure redistribution surface was used within the past 24 hours, 31) whether patient repositioning as prescribed has occurred within the past 24 hours, 32) whether the patient has received nutritional support within the past 24 hours, 33) moisture management has been used for the patient in the past 24 hours (e.g., used of a low airloss feature or microclimate management feature of a surface), 34) whether patient restraints are in use, 35) the type of restraint being used, 36) the category of restraint being used, 37) the justification for use of the restraint, 38) whether Continuous Veno-Venous Hemofiltration (CVVH)/Continuous Venovenous Hemodiafiltration (CVHD)/Femoral Lines are being used with the patient, 39) whether the patient has diabetes, 40) whether Extracorporeal Membrane Oxygenation (ECMO) is being used with the patient, 41) whether the patient has sepsis, 42) whether the patient has vascular disease, 43) whether vasopressors are being used for the patient or whether the patient has low mean arterial pressure (MAP), 44) whether the patient is ventilated, 45) whether the patient has a pressure injury, 46) pressure injury detail (e.g., location of wound such as right or left heel, sacrum, scapula, etc.; the stage of each wound; whether each wound was present at admission; whether each wound was present on arrival at the unit; and wound documentation), 47) whether any pressure injury is device related, 48) the type of device (if answer to 47 was “yes”), and 49) number of days from admission until the pressure injury was documented (if pressure injury was facility-acquired). The data from the IPUP survey is among the data communicated to the analytics engine 20. It should be appreciated that the IPUP survey data is input by a caregiver using a PC or tablet computer or some other computer device.

(18) According to the present disclosure, the analytics engine 20 processes the data received from sources 12 and performs risk assessments for the associated patient. As discussed in further detail below, the risk assessments include determining the risk of the patient developing sepsis, the risk of the patient developing a pressure injury (e.g., a pressure sore or decubitus ulcer), and the risk that the patient may fall. These are referred to herein as a sepsis risk assessment, a pressure injury risk assessment, and a falls risk assessment. This disclosure contemplates that the analytics engine 20 is able to make other risk assessments for the patient based on the data received from sources 12. Such risk assessments are dependent upon the type of sources 12 providing the data and the identification of a relatively close correlation between the data from the multiple sources 12 and a particular patient risk.

(19) Still referring to FIG. 1, the risk assessments are provided to caregivers or clinicians who may adjust or override the risk assessments based on clinical insights 24. The terms “caregiver” and “clinician” are used interchangeably herein. The adjustments to or overriding of the risk assessments based on the clinical insights 24 are implemented using a computer (not shown) such as a personal computer at a work station, a master nurse computer at a master nurse station, a mobile device such as a smart phone or tablet computer carried by a caregiver, and so forth. In some embodiments, each of the risk assessments results in a numerical score within a range of values between, and including, an upper limit and a lower limit. Thus, a caregiver is able to change the risk assessment scores output from the analytics engine 20 if, based on the caregiver's information about the patient and the caregiver's experience, such adjustment is warranted or otherwise desirable.

(20) Based on the risk assessments made by analytics engine 20 and the adjustments made by caregivers due to clinical insights 24, if any, the risk assessments are used to determine clinical services and actions 26 as indicated diagrammatically in FIG. 1. The ultimate goal of the risk assessments made by the analytics engine 20 and the implemented clinical services and actions 26 is to improve patient outcomes as indicated by the breakthrough outcomes block 28 of FIG. 1. For example, if the patient has sepsis or a high risk assessment for sepsis, clinicians may implement one or more of the following services and actions 26 (aka sepsis protocols): providing high-flow oxygen to the patient, drawing blood for laboratory testing such as testing the levels of lactates and hemoglobin, providing intravenous (IV) antibiotics, providing IV fluids, and performing an hourly urine output measurement.

(21) If the patient has a pressure injury or a high risk assessment for a pressure injury, clinicians may implement one or more of the following services and actions 26 (aka pressure injury protocols): a patient support surface therapy such as continuous lateral rotation therapy (CLRT) or alternating pressure therapy, applying a vacuum wound bandage to any pressure ulcer or wound of the patient, capturing an image of the wound(s) for a separate wound assessment, and monitoring the patient movement to assure the patient is repositioning themselves in bed 14 on a suitably frequent basis.

(22) If the patient is a falls risk or has a high risk assessment for falling clinicians may implement one or more of the following services and actions 26 (aka falls protocols): enabling a falls risk protocol on bed 14 which results in the bed circuitry and/or a remote computer (e.g., a bed status computer or nurse call computer) monitoring patient position on the bed 14, monitoring siderail position to confirm that designated siderails are in their raised positions, monitoring caster brake status to confirm that the casters are braked, and monitoring a position of an upper frame of the bed 14 to confirm that it is in a low position relative to a base frame of the bed 14; providing an incontinence detection pad of incontinence detection system 16 between the patient and a mattress of bed 14; providing a walker adjacent to the bed; and providing adequate food and/or water near the patient.

(23) Referring now to FIG. 2, a diagrammatic view shows various activities occurring around the patient bed 14 and also discloses aspects of a digital safety net (DSN) platform 30 based on the activities, the DSN platform including the analytics engine 20. The DSN platform also includes a Power over Ethernet (PoE) switch, router or gateway 32 (these terms are used interchangeably herein) that receives data from a multitude of sources 12, including bed 14, and routes risk assessment information to a plurality of output devices 34 which include graphical displays 36 and an indicator 38 (aka a dome light) of a nurse call system which provides visual information regarding the risk assessments performed by the analytics engine 20.

(24) Beneath the upper left image of FIG. 2, the bullet points indicate that there is an admitted patient in bed 14 and that an initial assessment of the patient has been conducted. In connection with initial assessment, the patient's medical history is taken, the patient's initial vital signs and weight are captured, a baseline pressure injury risk is assessed, and a photo of a suspected pressure injury is taken with a camera 40, illustratively a WOUNDVUE™ camera 40 available from LBT Innovations Ltd. of Adelaide, Australia, and uploaded to the analytics engine 20 for a wound assessment. An arrow 42 situated between the upper left image and the upper center image of FIG. 2 indicates that the data associated with the bullet points beneath the upper left image are communicated to the analytics engine of the DSN platform 30 of the upper center image.

(25) Beneath the upper center image of FIG. 2, the bullet points indicate that the analytics engine 20 of the DSN platform 30 has engaged a sepsis protocol in connection with assessing the patient's risk of developing sepsis; the patient's sepsis risk has been stratified or normalized into a score range of 1 to 5; the patient's condition is being monitored including monitoring the patient's temperature, the patient's motion, and a surface status of a patient support surface (aka a mattress) of bed 14. According to this disclosure, DSN platform 30 also engages a falls protocol in connection with assessing the patient's falls risk and engages a pressure injury protocol in connection with assessing the patient's pressure injury risk. The falls risk and pressure injury risk are also stratified or normalized by the analytics engine 20 into a score range of 1 to 5 in the illustrative example. In other embodiments, the risk ranges for each of the sepsis, falls, and pressure injury risks is 0 to 5. Thus, each of the sepsis, falls, and pressure injury risks has the same maximum value (e.g., 5 in the illustrative examples) and the same minimum value (0 or 1 in the illustrative examples). In other embodiments, different risk ranges are used such as those having upper limits greater than 5 including 10, 20, 25, 30, etc.

(26) Also beneath the upper center image of FIG. 2 are bullet points indicating that the risk levels or scores determined by the analytics engine 20 of the DSN platform 30 are displayed on the output devices 34 across the DSN platform 30 (i.e., at multiple locations throughout the healthcare facility) and that a rounding protocol is adjusted based on one or more of the determined risk scores for the patient's sepsis, falls, and pressure injury risks. With regard to graphical displays 36, the actual values of the scores are displayed in some embodiments, whereas with regard to the dome light 38, a portion of the dome light is illuminated in a particular manner based on the risk scores. For example, if any of the risk scores are 4 or 5, then a red light may be illuminated on the dome light 38 but if each of the risk scores is only 2 or 3, then a yellow or amber light may be illuminated on the dome light 38. If the risk scores are all at a lower level (e.g., 0 or 1 as the case may be), then the portion of the dome light relating to patient risk remains unlit. This lighting scheme for dome light 38 is given as one illustrative example and other lighting schemes are within the scope of the present disclosure, including having a portion or section of dome light 38 allocated to each risk score such that there are three risk light regions of dome light 38 corresponding to the sepsis, falls, and pressure injury risks, with each risk light region being illuminated red, yellow/amber, or unlit for different risk level scores of the associated risk. Other zones on the dome light indicate, for example, whether a caregiver is in the room, whether a patient in the room has placed a nurse call, or whether an equipment alarm in the room is active, including for semi-private rooms, which of two patients has placed the nurse call or which patient is associated with the equipment that is alarming. Dome lights that have portions that illuminate in colors other than red and yellow/amber, such as white, green, blue, purple, etc., are within the scope of the present disclosure.

(27) With regard to adjusting a rounding protocol, the rounding interval or time between caregiver rounds (i.e., the time between when an assigned caregiver is required to check on the patient) is shortened in some embodiments if one or more of the risk scores is high (e.g., level 4 or 5) or if a risk score increases from one level to the next (e.g., increasing from level 2 to level 3). It is contemplated by this disclosure that the higher a risk score is, the shorter the rounding interval will be. The correlation between rounding interval times and risk score levels, including summing two or three of the risk scores together for determining a rounding interval, is at the discretion of the system programmer or administrator. An arrow 44 situated between the upper center image and the upper right image of FIG. 2 indicates that after the activities associated with the bullet points beneath the upper center image are performed by the DSN platform 30, the bed 14 and vital signs equipment 18 (and other equipment as disclosed herein) continue to provide data to the analytics engine 20 for dynamic, real-time risk assessment.

(28) In some embodiments, adjustment of the rounding interval occurs dynamically, automatically, and substantially in real time as the risk scores increase and decrease. Thus, a rounding interval is decreased automatically from four hours to two hours if a risk score increases from, for example, a level 3 to level 4, and the rounding interval is increased from two hours to four hours, for example, if a risk score decreases from a level 4 to a level 3, just to give one arbitrary example to illustrate the concept. The rounding intervals are tracked and changed by an EMR computer or server or a nurse call computer or server in some embodiments. The rounding interval adjustments are made without human input or involvement at the computer or server that controls the rounding intervals in some embodiments. In other embodiments, a caregiver or clinician or other administrator at the rounding computer provides inputs to approve the rounding interval change. In either case, a rounding interval change notification is transmitted to the mobile device or devices of the affected caregiver(s) in some embodiments.

(29) The phrase “substantially in real time” as used herein means the amount of time that data measurements or values which contribute to the risk scores are received and are processed for re-calculation of the risk scores. Some equipment 12 may provide readings only once every minute or once every second and other equipment may provide readings 100 time per second, just to give some arbitrary examples. The present disclosure contemplates that the analytics engine 20 re-calculates risk scores each time a new data point is received and such is considered to be “substantially in real time” according to the present disclosure. The present disclosure also contemplates that the analytics engine 20 re-calculates risk scores only if a received measurement or value changes from a previous measurement or value. Thus, if a constant value is transmitted over and over again, the analytics engine does not re-calculate the risk score until one of the contributing measurements or values changes and this is also considered to be “substantially in real time” according to the present disclosure.

(30) Beneath the upper right image of FIG. 2, the bullet points indicate that the dynamic patient risk assessment by the analytics engine 20 includes monitoring, on an ongoing basis, whether patient support surface status is consistent with reduced pressure injury risk or whether the patient support surface status has changed in such a manner as to create an increased pressure injury risk. For example, if a bladder of the mattress of bed 14 has a leak and a sufficient amount of air is lost, the bladder pressure may decrease enough to permit a patient to bottom out through the mattress so as to be supported on the underlying mattress support deck rather than being supported by the bladder. Such a situation increases the risk that the patient may develop a pressure injury. According to this disclosure, the dynamic risk assessment by the analytics engine 20 also includes monitoring whether the patient's vital signs sensed by monitors 18 or by the on-bed vital sign sensors, are consistent and within desirable limits or whether the vital signs are changing in a manner indicative of declining health of the patient. If the latter scenario is detected, the patient's sepsis risk score is increased. Further according to this disclosure, the dynamic risk assessment by the analytics engine 20 also includes determining whether the patient is sleeping or not in the room, in which case the patient's falls risk score is decreased, or whether the patient is moving, agitated, or in pain, in which case the patient's falls risk score is increased. As the patient's risks scores increase or decrease, the clinical protocols for the patient are adjusted in a commensurate manner to match the changing risk level.

(31) An arrow 46 situated between the upper right image and the lower right image of FIG. 2 indicates that after a period of time, other conditions of the patient on bed 14 may be detected. As indicated by the bullet points beneath the lower right image of FIG. 2, if a patient change is detected by bed 14, such as lack of patient motion or patient motion below a threshold, for a prolonged period of time, and/or if a problematic surface change is detected, then a pressure injury algorithm executed by the analytics engine 20 determines that there is an increased risk of a pressure injury and the patient's pressure injury score is increased. Furthermore, in response to the increased pressure injury score, the analytics engine 20 initiates one or more alerts to one or more caregivers of the increased pressure injury risk and, in some embodiments, automatically activates a pressure injury prevention protocol such as reducing the rounding time automatically and/or implementing a surface therapy protocol such as sending reminder messages to a caregiver to turn the patient, to activate a turn assist function of bed 14 at regular intervals (e.g., every hour or every two hours), to activate an alternating pressure therapy of the mattress of bed 14, or to activate a CLRT therapy of the mattress of bed 14.

(32) If the analytics engine 20 receives data from bed 14 or vital signs monitors 18 resulting in an increased falls risk score or sepsis risk score, then the DSN platform 30 responds in a similar manner to alert caregivers of the increased score. For example, an increased patient heart rate coupled with increased patient movement may indicate that the patient is preparing to exit the bed 14 and the falls risk score may be increased accordingly. As another example, if the patient's heart rate or respiration increases but there is a lack of patient motion or patient movement below a threshold, thereby indicating a lethargic patient, then this may indicate an increased sepsis risk and the sepsis risk score may be increased accordingly.

(33) In each of these cases of increasing risk score, the analytics engine 20 initiates an alert to one or more caregivers assigned to the patient in some embodiments. Such alerts may be sent to a mobile device (e.g., pager, personal digital assistant (PDA), smart phone, or tablet computer) carried by the respective one or more caregivers. Such alerts may also be displayed on graphical displays 36 and dome lights 38 of system 10. As was the case for the increasing pressure injury score, a falls risk protocol or a sepsis protocol may be initiated automatically by the analytics engine 20 in response to an increasing falls risk score or increasing sepsis risk score, respectively.

(34) According to this disclosure, analytics engine 20 also provides risk score data or messages to sources 12, such as beds 14 and monitors 18 that are equipped with communications circuitry configured for bidirectional communication with analytics engine 20. Thus, in some embodiments, a message received by one or more of sources 12 from analytics engine 20 results in a risk reduction protocol or function of the source 12 being activated automatically (e.g., an alternating pressure function of a mattress being turned on automatically or an infusion pump for delivery of IV antibiotics being turned on automatically or a bed exit/patient position monitoring function of a bed being turned on automatically). In some embodiments, graphical displays of the sources 12, such as beds 14 and monitors 18, receiving such messages from analytics engine 20 display a message indicating that one or more of the pressure injury, falls, and sepsis risk scores have increased and, in appropriate circumstances, that a risk reduction protocol or function of the source 12 has been turned on or activated automatically.

(35) An arrow 48 situated between the lower right image and the lower left image of FIG. 2 indicates that a caregiver has been dispatched to the patient room of the patient whose risk score has increased. Thus, as indicated by the bullet points beneath the lower left image of FIG. 2, in response to an increasing pressure injury score, falls risk score, or sepsis risk score, the analytics engine 20 initiates an alert or notification to one or more assigned caregivers to immediately go to the patient's room and engage the patient. When the caregiver reaches the patient room, some of the risk factors resulting in the increased risk score may be addressed at that time. For example, the caregiver may assist a patient in going to the bathroom in response to an increase falls risk score or the caregiver may turn on a mattress turn assist function or therapy function for a patient having an increased pressure injury risk score or the caregiver may initiate delivery of IV antibiotics for a patient having an increased sepsis risk score.

(36) After the caregiver addresses the patients falls risk, pressure injury, and/or sepsis needs, the data provided to analytics engine 20, in some cases, will result in the respective risk score being decreased automatically. In some cases, however, the caregiver provides clinical insights 24 to the analytics engine 20 that result in a decreased risk score after the caregiver has addresses the patient's needs. In the case of an increased pressure injury score, the caregiver dispatched to the patient's room may be required, in some embodiments, to take a picture of any of the patient's pressure injuries using camera 40 for upload to analytics engine 20 so that the most recent pressure injury data is used in connection with determining the patient's pressure injury score.

(37) Referring now to FIG. 3, additional sources 12 of system 10 that provide data to analytics engine 20 via router or PoE switch 32 are shown. The additional sources 12 of FIG. 3 include a graphical room stations 50, patient lifts 52, and a locating system 54. Graphical room station 50 is included as part of a nurse call system such as the NAVICARE® Nurse Call system available from Hill-Rom Company, Inc. of Batesville, Ind. Additional details of suitable nurse call systems in which room stations 50 are included can be found in U.S. Pat. Nos. 7,746,218; 7,538,659; 7,319,386; 7,242,308; 6,897,780; 6,362,725; 6,147,592; 5,838,223; 5,699,038 and 5,561,412 and in U.S. Patent Application Publication Nos. 2009/0217080 A1; 2009/0214009 A1; 2009/0212956 A1; and 2009/0212925 A1, each of which is hereby incorporated by reference herein in its entirety for all that it teaches to the extent not inconsistent with the present disclosure which shall control as to any inconsistencies. Room stations 50 are among the sources 12 that caregivers use to provide clinical insights 24 into system 10 for analysis by analytics engine 20.

(38) Patient lifts 52 provide data to analytics engine 20 via router 32 in response to being used to lift a patient out of bed 14 for transfer to a stretcher, chair, or wheelchair, for example. The fact that a patient lift 52 needs to be used to move a patient to or from bed 14 is indicative that the patient is a falls risk because the patient is not able to exit from bed 14 and walk on their own or to get back onto bed 14 on their own. Thus, the falls risk score is increased by the analytics engine 20 in response to the patient lift 52 being used to move the patient. Furthermore, use of the patient lift 52 to move a patient to or from bed 14 also may be indicative that the patient is at higher risk of developing a pressure injury than an ambulatory patient. For example, lifts 52 are oftentimes used to transfer paraplegic or quadriplegic patients and such patients, while in bed, have limited ability to shift their weight to reduce the chances of developing pressure injuries. Also, slings used with patient lifts sometimes produce high interface pressures on portions of the patient, such as the patient's hips or sacral region, which also may increase the risk of developing a pressure injury. Thus, in some embodiments, use of lift 52 not only results in an increase in the patient's falls risk score but also an increase in the patient's pressure injury score.

(39) The illustrative image of patient lift 52 in FIG. 3 is an overhead lift 52 that is attached to a framework installed in the patient room. Other types of patient lifts 52 include mobile patient lifts which are wheeled into a patient room for use. A set of wireless communication icons 56 are included in FIG. 3 to indicate that some of sources 12 of network 10 communicate wirelessly with the gateway 32, such as via one or more wireless access points (not shown) for example. In particular, icons 56 of FIG. 3 indicate that beds 14, monitors 18, patient lifts 52, components of locating system 56, and components of incontinence detection system 16 communicate wirelessly with gateway 32. The lines extending from sources 12 to gateway 32 in FIG. 3 indicate that the sources may communicate via wired connections with gateway 32 in addition to, or in lieu of, the wireless communication.

(40) In some embodiments, the sources 12 that are able to communicate wirelessly have dedicated circuitry for this purpose. Alternatively or additionally, locating tags of locating system 54 are attached to sources 12, such as beds 14, monitors 18, patient lifts 52, and components of incontinence detection system 16. Locating tags of system 54 are also attached to caregivers and/or patients in some embodiments. The locating tags include transmitters to transmit wireless signals to receivers or transceivers installed at various fixed locations throughout a healthcare facility. In some embodiments, the tags have receivers or transceivers that receive wireless signals from the fixed transceivers. For example, to conserver battery power, the locating tags may transmit information, including tag identification (ID) data, only in response to having received a wireless signal from one of the fixed transceivers. The fixed receivers or transceivers communicate a location ID (or a fixed receiver/transceiver ID that correlates to a location of a healthcare facility) to a locating server that is remote from the various fixed transceivers. Based on the tag ID and location ID received by the locating server, the locations of the various tagged equipment of sources 12, the tag wearing caregivers, and the tag wearing patients is determined by the locating server.

(41) With the foregoing discussion in mind, if a mobile patient lift 52 is determined by the locating system 54 to be in the room of a patient, analytics engine increases the pressure injury risk score and/or the falls risk score for the patient in some embodiments. A similar increase in the sepsis risk score may be made by the analytics engine 20 if certain equipment is determined by locating system 54 to be in the patient room. For example, if a heart rate monitor, respiration rate monitor, and blood pressure monitor are all locating in the patient room for a threshold period of time, then the sepsis risk score is increased by the analytics engine 20 in some embodiments. If a bag or bottle of IV antibiotics in the patient room has a locating tag attached, then the sepsis risk score is increased by the analytics engine 20 in some embodiments.

(42) If an incontinence detection pad of incontinence detection system 16 is determined to be in the patient room, either due to detection of a locating tag attached to the pad by locating system 54 or due to detection of the incontinence detection pad by the circuitry of bed 14 or due to a reader of incontinence detection system 16 providing data to analytics engine 20, possibly via the nurse call system in some embodiments, then the patient's falls risk score and/or the patient's pressure injury score is increased by the analytics engine in some embodiments. Use of an incontinence detection pad with the patient is indicative that the patient is not sufficiently ambulatory to get out of bed 14 and go to the bathroom on their own, and therefore, the patient is a falls risk patient. Furthermore, use of an incontinence detection pad with the patient is indicative that the patient may be confined to their bed 14 which increases the risk of developing a pressure injury. In some embodiments, in response to incontinence detection system 16 detecting that the patient has soiled the incontinence detection pad and that the pad has remained beneath the patient for a threshold amount of time thereafter before being replaced with an unsoiled pad, then the pressure injury risk score is increased by the analytics engine because prolonged exposure to moisture or wetness increases the chance that the patient will develop a pressure injury.

(43) In some embodiments, locating system 54 operates as a high-accuracy locating system 54 which is able to determine the location of each locating tag in communication with at least three fixed transceivers within one foot (30.48 cm) or less of the tag's actual location. One example of a high-accuracy locating system 54 contemplated by this disclosure is an ultra-wideband (UWB) locating system. UWB locating systems operate within the 3.1 gigahertz (GHz) to 10.6 GHz frequency range. Suitable fixed transceivers in this regard include WISER Mesh Antenna Nodes and suitable locating tags in this regard include Mini tracker tags, all of which are available from Wiser Systems, Inc. of Raleigh, N.C. and marketed as the WISER LOCATOR™ system. UWB locating systems available from other manufacturers may be used just as well. In some embodiments, the high-accuracy locating system 54 uses 2-way ranging, clock synchronization, and time difference of arrival (TDoA) techniques to determine the locations of the locating tags. See, for example, International Publication No. WO 2017/083353 A1, which is hereby incorporated by reference herein in its entirety for all that it teaches to the extent not inconsistent with the present disclosure which shall control as to any inconsistencies, for a detailed discussion of the use of these techniques in a UWB locating system.

(44) In those embodiments in which locating system 54 is a high-accuracy locating system 54, a more granular set of rules for determining whether to increment or decrement a particular risk score may be implemented by analytics engine 20. For example, rather than increasing the falls risk score and/or pressure injury score in response to detection of a patient lift 52 in the room or detection of an incontinence detection pad in the room, the particular risk score is only incremented if the relative position between the lift 52 or incontinence detection pad and the patient bed 14 meets certain criteria. For example, the falls risk and/or pressure injury risk score is not incremented until a motorized lift housing and/or sling bar of the overhead lift 52 are determined to be located over a footprint of the hospital bed 14. This prevents the risk score(s) from being increased or incremented if the overhead lift 52 is not in use with the particular patient but is simply stored off to the side of the bed 14 or in a corner of the room. In a similar way, the falls risk and/or pressure injury risk score is not incremented until a mobile lift 52 is determined to be within a threshold distance, such as 1 or 2 feet of the bed 14 or patient just to give a couple arbitrary examples. Further similarly, the falls risk and/or pressure injury risk score is not incremented until the incontinence detection pad is determined to be within a footprint of the hospital bed 14.

(45) Still referring to FIG. 3, the graphical displays 36 of output devices 34 include status boards 58, graphical audio stations 50, and mobile devices 60 of caregivers. The illustrative mobile devices 60 of FIG. 3 are smart phones, but as indicated above, mobile devices 60 also include pagers, PDA's, tablet computers, and the like. Status boards 58 are oftentimes located at master nurse stations in healthcare facilities but these can be located elsewhere if desired, such as in staff breakrooms, hallways, and so forth. In some embodiments, the status boards 58 are included as part of the nurse call system. In this regard, see, for example, U.S. Pat. No. 8,779,924 which is hereby incorporated by reference herein in its entirety to the extent not inconsistent with the present disclosure which shall control as to any inconsistences. This disclosure contemplates that the status board has additional fields for displaying the falls risk, pressure injury risk, and sepsis risk scores for each of the listed patients on the status board.

(46) As is apparent in FIG. 3, graphical room stations 50 serve as both sources 12 for providing data to the analytics engine 20 and as output devices 34 for displaying data from the analytics engine 20. Thus, graphical room stations 50 also have display screens with fields for displaying the falls risk, pressure injury risk, and sepsis risk scores for the patients located in the rooms having the room stations 50. In some embodiments, stations 50 are operable to obtain and display the risk scores of patients located in other rooms. Thus, a caregiver using the room station 50 in one room may be communicating with another caregiver, such as a nurse at a master nurse station, about a patient located in another room and can pull up information, including the risk scores, pertaining to the other patient being discussed.

(47) Mobile devices 60 also have screens with fields to display the risk scores of patients. In some embodiments, a mobile software application is provided on the mobile devices 60 of caregivers and operates to limit the caregiver's ability access to information, such as only being able to see the risk scores for their assigned patients and not those of patients assigned other caregivers. Furthermore, it is contemplated by this disclosure that a pop-up window may appear on the caregiver's mobile device each time a risk score changes for any of the caregiver's assigned patients. Examples of screens that appear on mobile devices 60 in some embodiments are discussed below in connection with FIGS. 7-10.

(48) An electronic medical records (EMR) or health information systems (HIS) server 62 is also communicatively coupled to the analytics engine 20 via PoE switch 32 as shown in the illustrative example of FIG. 3. Server 62 is coupled to one or more EMR or HIS computers (not shown) that have display screens for showing the risk scores of the various patients of the healthcare facility. In some embodiments, server 62 is also a source 12 of data for analytics engine 20 to use in connection with determining the risk scores of the various patients. Analytics engine 20 is also communicatively coupled to an Internet of Things (IoT) network or platform 64 via gateway 32 as shown in FIG. 3. Platform 64 receives information from multiple healthcare facilities and operates to analyze the incoming information to identify best practices for risk reduction protocols that, in turn, may be shared with other healthcare facilities that may subscribe to receive such best practice information. The best practice information may include relevant thresholds to use in risk assessment algorithms, steps to implement in a standard of care to keep patient risks to a minimum, and corrective actions to take in response to elevated patient risk scores, for example. Platform 64 also may implement analytics for predicting patient outcomes and communicate the predictions to subscribing healthcare facilities, for example.

(49) As indicated in FIG. 3, analytics engine 20 communicates bidirectionally with some or all of sources 12, output devices 34, server 62, and platform 64. Analytics engine 20 comprises one or more servers or other computers that implement analytics software that is configured in accordance with the various algorithms and rules discussed above. It should be appreciated that FIGS. 1-3 are diagrammatic in nature and that other network infrastructure communicatively interconnects each of the devices of system 10 discussed above in each healthcare facility in which system or apparatus 10 is implemented. Another diagrammatic example of network infrastructure is discussed below in connection with FIG. 6.

(50) Referring now to FIGS. 4A-4C, a flow chart 70 shows an example of a patient's journey beginning at an emergency department (ED) indicated by block 72 or Surgical unit indicated by block 74, then moving on to an intensive care unit (ICU) or a medical/surgical (MED/SURG) unit indicated by block 76, and then home or to a long term care (LTC) facility or a skilled nursing facility (SNF) as indicated by block 78. Flow chart 70 shows locations within the patient flow at which the analytics engine 20 of DSN platform 30 operates to determine the patient's risk of having or developing sepsis. Wherever in flow chart 70 the DSN platform 30 is invoked for patient risk assessment of sepsis, a DSN platform block 80 is shown.

(51) Referring now to FIG. 4A, a patient arrives in a hospital at the ED 72 as indicated at block 82 and is triaged and screened for sepsis as indicated at block 84. This initial screening is for the purpose of early detection of sepsis as indicated by Early Detection cloud 86 above ED 72. The information from the screening at block 84 is provided to DSN platform 30 as indicated by the associated block 80 and then a determination is made as to whether it is suspected that the patient has sepsis as indicated at block 88. The determination at block 88 is made by analytics engine 20 based on information communicated from DSN 30 as indicated by Communication cloud 90 above block 88.

(52) If it is determined at block 88 that sepsis is suspected, then the patient gets Lactic Acid Culture (LAC) and Complete Blood Count (CBC) tests ordered as indicated at block 92. Lactic acid (aka lactate) in the blood greater than 2 millimoles per liter (mmol/L) is one of the indicators that the patient has sepsis. According to some sepsis determination protocols, this level of lactate in the blood is considered in combination with other sepsis risk factors including one or more of the following: i) systolic blood pressure being less than 90 millimeters of Mercury (mmHg) or a mean arterial blood pressure being less than 65 mmHg; ii) heart rate being greater than 130 beats per minute, iii) respiratory rate being greater than 25 breaths per minute, iv) oxygen saturation (e.g., SpO2) being less than 91%, v) the patient being unresponsive or responds only to voice or pain, and/or vi) the presence of a purpuric rash. According to other sepsis determination protocols, sepsis is determined to be likely if the following criteria are met: i) the patient's temperature is greater than about 38.3° Celsius (C) (about 101° Fahrenheit (F)) or less than about 35.6° C. (about 96° F.), ii) the patient's heart rate is greater than 90 beats per minute; and iii) the patient's respiration rate is greater than 20 respirations per minute. Thus, different healthcare facility have different sepsis determination protocols and all such protocols are within the scope of the present disclosure.

(53) After the blood test of block 92, a determination is made as to whether or not the patient has sepsis as indicated at block 94. If the patient has sepsis, as determined at block 94, then a 3 hour (Hr) bundle is kicked-off as indicated at block 96. A 3 Hr bundle includes, for example, administration of broad spectrum antibiotics and administering 30 milliliters per kilogram (mL/kg) of Crystalloid for Hypotension or Lactate greater than or equal to 4 mmol/L. The 3 Hr bundle also may include measuring Lactate level and obtaining blood cultures at some healthcare facilities, but in FIG. 4A, these were done at block 92 prior to kicking off the 3 Hr bundle at block 96. Above block 96 are a Correct Billing Code cloud 97 and a Bundle Compliance Cloud 98 which, in some embodiments, may invoke monitoring and feedback to caregivers by the DSN platform 30 or the HIS server 62.

(54) A box 100 at the top of FIG. 4A includes bullet points indicative of equipment and systems used in connection with the portion of flow chart 70 shown in FIG. 4A. In particular, box 100 lists multi-parameter vitals devices, physical assessment devices, beds, ECG carts, and clinical workflow (nurse call) systems. These systems and equipment are sources 12 to analytics engine 20 of DSN platform 30 in some embodiments. A box 102 at the bottom of FIG. 4A includes bullet points indicative of aspects of the DSN platform 30 used in connection with the portion of flow chart 70 shown in FIG. 4A. In particular, box 102 lists advanced analytics to augment clinical decision making and early detection of conditions (e.g., analytics engine 20), smart sensing beds or stretchers (e.g., beds 14 having vital signs sensors or integrated incontinence detection system 16), wearable or contact free parameter sensing (e.g., some embodiments of monitors 18), integration of parameters from sources of multiple companies (e.g., vitals monitors 18 of various companies), and mobile communication platform to optimize workflow (e.g., caregiver mobile devices 60).

(55) If at block 88 of FIG. 4A sepsis is not suspected, or if at block 94 of FIG. 4A it is determined that the patient does not have sepsis, then the patient is admitted to the healthcare facility and is sent to a Med/Surg unit as indicated at block 76 of FIG. 4B (Cont.). The information regarding a negative sepsis suspicion or determination at blocks 88, 94 may be communicated to the analytics engine 20 of DSN platform 30 in connection with the patient being sent to the Med/Surg unit in some embodiments. Thus, two out of the three flow paths exiting from the right hand side of FIG. 4A, lead to the patient being admitted and sent to the Med/Surg unit as indicated at block 76 of FIG. 4B (Cont.). As shown in FIG. 4B, instead of arriving at the emergency department, it is contemplated that a patient arrives at the Surgical unit 74 of the hospital for surgery as indicated at block 104 within surgical unit 74. Thereafter, the patient has surgery as indicated at block 106. During or after surgery, the patient's vitals (i.e., vital signs) are measured and the patient is screened for sepsis while in the Surgical unit 74 as indicated at block 108 of FIG. 4B. In this regard, Early detection cloud 86 is also shown in FIG. 4B above the Surgical unit 74.

(56) After surgery, the patient's vitals information and sepsis screening information from block 108 is provided to the analytics engine 20 of the DSN platform 80 and then the patient is admitted to the healthcare facility and is sent to the Med/Surg unit as indicated at block 76 of FIG. 4B (Cont.). After the patient is admitted to the Med/Surg unit at block 76, Q4 vitals and Best Practice Alerts (BPA) for sepsis are implemented as indicated at block 110 and the associated data is provided to the analytics engine 20 of the DSN platform as indicated by block 80 adjacent to block 110. Q4 vitals are vitals that are taken 4 hours apart, such as 8 am, noon, 4 pm, 8 pm, midnight, 4 am, etc. Early Detection cloud 86 is shown above block 110 in FIG. 4B as is a Frequency of Data cloud 112. Thus, cloud 112 above block 110, indicates that caregivers may change the frequency of taking the patient's vital signs to Q1, Q2, or Q8 (i.e., one, two or eight hours apart, respectively, instead of four hours apart) based on clinical insights 24.

(57) Based on the data obtained in connection with block 110, a determination is made as to whether it is suspected that the patient has sepsis as indicated at block 114. If it is determined at block 114 that sepsis is not suspected, the work flow 70 returns back to block 110 and proceeds from block 110. If it is determined at block 114 that sepsis is suspected, then the patient gets LAC and CBC tests ordered as indicated at block 116. The LAC and CBC tests were discussed above in connection block 92 of FIG. 4A and the same discussion is applicable to block 116 of FIG. 4B (Cont.). The results of the LAC and CBC are communicated to the analytics engine 20 of the DSN platform 30 as indicated by the block 80 that is situated above block 116 in FIG. 4B (Cont.).

(58) Based on the results of the LAC and CBS tests at block 116, a determination is made as to whether the patient has sepsis as indicated at block 118. If at block 118 it is determined that the patient does not have sepsis, the workflow 70 returns back to block 110 and proceeds from block 110. If the patient has sepsis, as determined at block 118, then a 3 Hr bundle is kicked-off as indicated at block 120. The 3 Hr bundle was discussed above in connection with block 96 of FIG. 4A and the same description is applicable to block 120 of FIG. 4B (Cont.). Above block 120 are Correct Billing Code cloud 97 and Bundle Compliance cloud 98 which, in some embodiments, may invoke monitoring and feedback to caregivers by the DSN platform 30, as indicated by block 80 to the right of block 120, or by the HIS server 62. After the 3 Hr bundle is kicked-off at block 120 of FIG. 4B, the patient is evaluated as indicated at block 122 of FIG. 4B (Cont.).

(59) A box 124 at the top of FIG. 4B includes bullet points indicative of equipment and systems used in connection with the portion of flow chart 70 shown in FIGS. 4B and 4B (Cont.). In particular, box 124 lists multi-parameter vitals devices, physical assessment devices, beds, clinical workflow (nurse call) systems, real time locating solutions (RTLS's), patient monitoring solutions, clinical consulting services, ECG carts, and patient mobility solutions. These systems (or solutions) and equipment of block 124 are sources 12 to analytics engine 20 of DSN platform 30 in some embodiments. A box 126 at the bottom of FIG. 4B (Cont.) includes bullet points indicative of aspects of the DSN platform 30 used in connection with the portion of flow chart 70 shown in FIGS. 4B and 4B (Cont.). In particular, box 126 lists advanced analytics to augment clinical decision making and early detection of patient deterioration (e.g., analytics engine 20), wearable or contact free parameter sensing (e.g., some embodiments of monitors 18), smart sensing beds (e.g., beds 14 having vital signs sensors or integrated incontinence detection system 16), integration of parameters from sources of multiple companies (e.g., vitals monitors 18 of various companies that output vital signs, including cardiac output), and mobile communication platforms (e.g., caregiver mobile devices 60).

(60) After the 3 Hr bundle of block 96 of FIG. 4A is kicked off, the patient is evaluated as indicated at block 128 of FIG. 4B and data regarding the 3 Hr bundle is provided to the analytics engine 20 of the DSN platform 30 as indicated by the block 80 in FIG. 4B which is situated to the left of block 128. The data obtained during the evaluation of the patient at block 128 is provided to the analytics engine 20 of the DSN platform as indicated by the block 80 to the right of block 128. In the illustrative example, a 6 Hr bundle is kicked off as indicated at block 130 after the data from the patient evaluation of block 128 has been analyzed by the analytics engine 20 of the DSN platform. The 6 Hr bundle, in some embodiments, includes applying vasopressors to maintain MAP greater than or equal to 65 mmHg, measuring central venous pressure (CVP), measuring central venous oxygen saturation (S.sub.CVO2), and re-measuring lactate if initial lactate level was elevated. The 6 Hr bundle may vary from healthcare facility to healthcare facility. After the 6 Hr bundle of block 130, the patient is evaluated once more as indicated at block 132 and the data from the evaluation, including information regarding the steps of the 6 Hr bundle of block 130, is provided to the analytics engine 20 of the DSN platform 30 as indicated by the block 80 to the right of block 132 in FIG. 4B.

(61) If the patient evaluation at block 122 or at block 132, as the case may be, indicates that the patient no longer has sepsis, as is the case in the illustrative example of flow chart 70, then the patient is discharged to return home or to an LTC facility or to an SNF as indicated at block 78 of FIG. 4C. A Home Monitoring Readmission cloud 134 is situated above block 78 to indicate that continued monitoring of the patient's condition while at home is contemplated. In this regard, a box 136 at the top of FIG. 4C includes bullet points indicative of equipment and systems used in connection with the portion of flow chart 70 shown in FIG. 4C. In particular, box 136 lists home health monitoring (BP and weighing scales), ambulatory cardiac monitoring (including vitals monitoring equipment 18 such as an ambulatory blood pressure monitor (ABPM), a Holter monitor, and/or a TAGecg device), and an airway clearance device. These at-home devices and equipment of block 136 are also sources 12 to analytics engine 20 of DSN platform 30 in some embodiments. Thus, such at-home sources 12 communicate with analytics engine 20 via the Internet in some embodiments.

(62) A box 138 at the bottom of FIG. 4C includes bullet points indicative of aspects of the DSN platform 30 used in connection with the portion of flow chart 70 shown in FIG. 4C. In particular, box 138 lists advanced analytics for early detection of patient conditions at home (e.g., analytics engine 20), remote patient monitoring of multiple parameters and related communication platforms, wearable or contact free parameter sensing (e.g., some embodiments of monitors 18), smart sensing beds (e.g., beds 14 having vital signs sensors or integrated incontinence detection system 16), and integration of parameters from sources of multiple companies (e.g., vitals monitors 18 of various companies that output vital signs).

(63) Referring now to FIGS. 5A and 5B, a flow chart 140 is provided showing an example of a patient's admission and stay at a healthcare facility including use of equipment in the patient's room to move the patient and showing locations within the patient flow at which the analytics engine 20 operates to make a risk assessment for the patient. At block 142 of FIG. 5A of flow chart 140, a patient is transported to a patient room on a stretcher. Thereafter, the patient is transferred from the stretcher to the patient bed 14 in the room as indicated at block 144. At this point, the patient is admitted to the healthcare facility as indicated at block 146. In some embodiments, the patient is admitted prior to being transported to the patient room.

(64) Once in the room, a nurse assesses the patient as indicated at block 148 of FIG. 5A. As shown in block 148, if a real time locating system (RTLS) determines that a caregiver is located in the patient room, then information on a display board, displays of mobile devices 60, displays 50 of the nurse call system, and status board 58 are updated to indicate the caregiver's presence in the room. Block 148 also indicates that the nurse assesses the bed condition (e.g., siderails in proper position, caster brakes are set, etc.), assesses the patient, conducts an assessment of monitors 18, checks patient temperature, documents patient anxiety level in connection with a heart rate assessment, activates a Patient Safety Application (PSA) (e.g., enables or arms a bed exit/patient position monitoring (PPM) system), and arms bed rails (e.g., indicates which siderails should be in the raised position in connection with the bed exit/PPM system).

(65) As indicated at block 150 to the right of block 148, a feed from an admission/discharge/transfer (ADT) system is received by the nurse call system of the healthcare facility and, if the ADT feed indicates the patient is a falls risk, the nurse call system sends a message to the bed 14 associated with the patient to arm systems on bed 14 (e.g., arm the bed exit/PPM system and monitor bed siderail position, caster brake status, etc.) as indicated at block 152. In the illustrative example of FIG. 5A, bed pressure sensors are used to monitor patient movement as indicated at block 154 to the right of block 152. Alternatively or additionally, load cells of a weigh scale system of the bed 14 monitors patient movement.

(66) As indicated at block 156 of FIG. 5A beneath block 154, some or all of the information obtained in the nurse assessment of block 148 is displayed on one or more display devices such as output devices 34 discussed above. Furthermore, as indicated in block 158 down and to the left of block 156, bed 14 sends patient safety status information for displays such as a display at a foot end of the bed, a display board (e.g., status board 58), one or more patient monitoring devices 18, and mobile devices 60 (the “Clarion application” listed in block 158 is software used by mobile devices 60 for caregiver-to-caregiver communication and for communication of alerts (aka alarms) and device data). In some embodiments, the “Clarion application” is the LINQ™ mobile application available from Hill-Rom Company, Inc.

(67) The data associated with blocks 148, 150, 152, 154, 156, 158 is also captured for predictive analysis by analytics engine 20 of the DSN platform as indicated by block 160 to the left of block 158. In this regard, the analytics engine 20 receives patient movement data as monitored by load cells of bed 14 as indicated at block 162 to the left of block 160, and then communicates messages indicative of patient probability of bed exit and notifies one or more clinicians of the probability as indicated at block 164. As indicated at block 166 below block 164 in FIG. 5A, if a clinician enters the patient room, the PSA disables any alarms associated with features monitored by the PSA.

(68) In the illustrative example of flow chart 140 of FIG. 5A, the clinician uses a patient lift to move the patient from the bed 14 to a wheelchair as indicated at block 168. Thereafter, as indicated at block 170, the clinician transports the patient to a toilet, such as a toilet in a bathroom included as part of the patient room, for example. Block 170 also indicates that a toilet seat identifies the patient as being present (e.g., sitting on the toilet seat) which results in a change of status on one or more of the displays of output devices 34 to toilet status for the patient and also indicates on the displays that the caregiver is in the room.

(69) After the patient is finished using the bathroom, the clinician transports the patient to a chair in the room using the wheelchair as indicated at block 172 of FIG. 5B. Block 172 also indicates that the chair identifies the patient as being present (e.g., sitting on the chair) which results in a change of status on one or more of the displays of output devices 34 to Patient-in-Chair status for the patient and one or more of these displays also continue to indicate that the caregiver is in the room. Block 172 further indicates that the chair senses patient movement. Thus, this disclosure contemplate that the chair has load cells, pressure sensors, force sensitive resistors (FSR's), or the like, along with associated circuitry, to sense patient position in the chair and to communicate the patient position in the chair to the analytics engine 20. As indicated in block 174 to the left of block 172, in the illustrative example of flow chart 140, the clinician hands the patient a nurse call communication device (e.g., a pillow speaker unit) that the patient can use to place a nurse call if assistance is needed after the caregiver leaves the patient room while the patient is sitting in the chair.

(70) While the patient is sitting in the chair, the analytics engine 20 of the DSN platform 30 captures data from the chair for predicative analysis of chair exit as indicated at block 176 to the left of block 174 in FIG. 5B. In the given example, patient movement is monitored by chair pad pressure cells as indicated at block 178 to the left of block 176. As indicated by block 180 below blocks 176, 178 in the illustrative flow chart 140, the clinician leaves the room, the caregiver's status of no longer being present in the room is updated on the displays of bed 14, monitors 18, display boards 50, 58 of output devices 34, and the displays of mobile devices 60 but the patient's status as Patient-in-Chair remains on these displays.

(71) As indicated in block 182 which is situated to the right of block 180 and beneath block 174 in FIG. 5B, system 10 indicates patient probability of chair exit by the patient and notifies one or more clinicians of the probability. Thereafter, a nurse enters the room as indicated at block 184. In response to the caregiver entering the room, the PSA receives information from the locating system that the caregiver is in the room, silences alarms on the bed 14, and sends a message resulting in one or more of displays of bed 14, monitors 18, display boards 50, 58 of output devices 34, and the displays of mobile devices 60 being updated to indicate that the caregiver is in the room.

(72) In the illustrative example of flow chart 140, after the caregiver enters the room at block 184, the caregiver transports the patient back to bed 14 as indicated at block 186. Thereafter, the bed siderails are raised as indicated at block 188 and the caregiver leaves the room. As also indicated in block 188, the PSA receives information from the locating system that the caregiver has left the room and sends a message resulting in one or more of displays of bed 14, monitors 18, display boards 50, 58 of output devices 34, and the displays of mobile devices 60 being updated to indicate that the caregiver is out of the room and that the patient is in bed. Thereafter, data is captured from bed 14 relating to patient movement and the predictive analysis of bed exit at analytics engine 20 of the DSN platform 30 begins again as indicated at block 190 of FIG. 5B.

(73) Based on the foregoing, it is apparent that data is generated by a number of devices 14, 16, 18 and other sources 12 as described above and sent to the analytics engine 20 of DSN platform 30. The algorithms of analytics engine establish a risk profile (e.g., risk scores) for each patient based on protocols established by a given healthcare facility. Some or all of the devices 14, 16, 18 and other sources 12 are updated with the risk profile information. In some embodiments, the sources 12 have displays that provide guided steps to caregivers that can be taken by the caregivers at the point of care to reduce or mitigate the risk profiles. The risk profiles for each patient are updated in substantially real time by the analytics engine as the incoming data changes. In some embodiments, the analytics engine 20 also sends data to other systems, such as IoT platform 64, for further analysis.

(74) Referring now to FIG. 6, a diagrammatic view of another system 10, similar to FIG. 3, is provided and shows hospital on-premises equipment at the left side of the page including in-room devices 12, device gateway 32, and a status board 58. The illustrative in-room devices 12 of FIG. 6 include hospital bed 14, incontinence detection system 16, vital signs monitor 18, and room station 50. However, devices 12 of system 10 of FIG. 6 can include any other type of device 12 discussed herein. System 10 of FIG. 6 further includes cloud devices 200 at a center of the page including an enterprise gateway (HL7) 202, a clinical data repository 204, a risk engine 206, and analytics platform 20 that implements artificial intelligence (AI) to process data in some embodiments. Additional on-premises equipment of system 10 of FIG. 6 is shown at the right side of the page includes one or more mobile devices 60 and 3.sup.rd party solutions 208 including EMR server 62, an ADT server 210, and a Labs server 212.

(75) As indicated in FIG. 6, messages and/or data transmitted to 3.sup.rd party solutions 208 from devices 12 via gateway 32 and from clinical data repository 204, risk engine 206, and analytics platform 20 pass through enterprise gateway (HL7) 202. Thus, gateway 202 converts the various messages and data into the health level 7 (HL7) format for subsequent delivery to the 3.sup.rd party devices 208 such as EMR, ADT, and Labs servers 62, 210, 212. In the embodiment of system 10 in FIG. 6, risk engine 206 manages the risk levels of the pressure injury risk score, falls risk score, and sepsis risk score based on the incoming data from devices 12 and the analytics platform (aka analytics engine) 20 analyzes the incoming data from devices 12 to determine correlations to the various patient risk scores.

(76) According to the present disclosure, a multitude of devices 12 provide a multitude of types of data (e.g., patient data, vital signs data, physiological data, device data, etc.) to the analytics engine 20 which processes the data and determines one or more risk scores based on the data. The risk scores are adjusted substantially in real time as new data is received by the analytics engine 20. In the discussion above, risk scores relating to pressure injuries, falls, and sepsis were given as risk score examples. However, the present disclosure contemplates that other risk scores pertaining to other patient risks can be established at the discretion of a designer or programmer of system 10. In this regard, the following table is a list of the types of data (referred to as “risk factors” that may contribute to risk scores according to the present disclosure, including contributing to the risk scores relating to pressure injuries, falls, and sepsis:

(77) TABLE-US-00001 TABLE 1 Risk factor rfid rfid_type Description Type Abdominal Aortic 1 0 Associated Aneurysm Surgery admission DX Abdominal 2 0 Clinical exam Respirations Abnormal Lung 3 0 Diminished, Clinical exam Sounds wheezes, Crackles Accessory Muscle 4 1 Patient symptoms Use Accessory Muscle 4 2 intracostals and Clinical exam Use Sub-clavicular retractions Acute Myocardial 5 0 Associated Ischemia admission DX Acute Pancreatitis 6 0 Associated admission DX Age 7 0 Demographics Autoimmune 8 0 Comorbidities disease, acquired autoimmune disease, acquired immune deficiency syndrome (AIDS), Immune Suppression or HIV Albumin 9 0 Labs Altered mental 10 0 Patient symptoms status or Confusion Anemia 11 0 Comorbidities Anticoagulants (IV 12 0 Medications or SC) ex. heparin, lovenox Anxiety 13 0 Patient symptoms Any delivery other 14 0 Charted MD orders than cannula (venturi, rebreather, Non-Rebreather, CPAP, BiPAP) Any New Complaint 15 0 Patient symptoms in last 24 hrs Arterial Blood Gases 16 0 Charted MD orders Arterial PaO2 17 0 (Decreased) Labs Arterial PCO2 18 0 (abnormal) Labs Arterial Ph 19 0 Labs (Acidosis) Aspiration 20 0 Associated admission DX Asthma 21 1 Associated admission DX Asthma 21 2 Comorbidities Blood Transfusion 22 0 Procedures Brain Natriuretic 23 0 (lab order) Charted MD orders Peptide Brain Natriuretic 24 0 (Elevated) Labs Peptide Breathing treatments 25 0 Charted MD orders Bronchodilators 26 0 Medications Bronchiectasis or 27 0 Associated atelectasis admission DX Bronchitis 28 0 Associated admission DX Blood Urea Nitrogen 29 0 BUN Labs Burns 30 0 Associated admission DX Cancer 31 1 Associated admission DX Cancer 31 2 Comorbidities Capillary refill time 32 0 >3 seconds Clinical exam Cardiac Ejection 33 0 (decreased) Labs Fraction Cardiac or Thoracic 34 0 Associated Surgery admission DX Cardiac Valve 35 0 Associated Disorder or Valvular admission DX Insufficiency Chemotherapy (aka 36 0 Associated Chemo) admission DX Chest pain 37 0 Patient symptoms Chest pressure or 38 0 Clinical exam pain or Abnormal ECG Chest x-ray 39 0 Charted MD orders Chronic Congestive 40 0 Comorbidities Heart Failure or Congestive Heart Disease Chronic Obstructive 41 0 Comorbidities Pulmonary Disease Congestive Heart 42 0 Associated Failure admission DX COPD Exacerbation 43 0 Associated admission DX Corticosteriods 44 0 Medications Cost of Prior care 45 0 Demographics Cough 46 1 Clinical exam Cough 46 2 Patient symptoms Creatinine 47 0 (Increased) Labs Cyanosis 48 1 Clinical exam Cyanosis 48 2 Patient symptoms Cystic Fibrosis 49 0 Comorbidities Decreased level of 50 0 Clinical exam consciousness (LOC)(from AVPU of modified early warning score (MEWS) or Glasgow Coma Scale (GCS) or Facility specific or agitation or encephalopathy) Deep Vein 51 0 Associated Thrombosis admission DX Dementia 52 0 Comorbidities Diaphoresis 53 0 Patient symptoms (sweating) Diuretic Use 54 0 Medications Doppler 55 0 Charted MD orders Echocardiography (imaging) Drug Overdose 56 0 Associated admission DX Dyspnea 57 0 Patient symptoms Dyspnea at rest 58 0 Associated admission DX Emergency Surgery 59 0 Associated admission DX Emphysema 60 0 Comorbidities Alcohol (EtOH) 61 0 Comorbidities Abuse or Drug Abuse including intravenous (IV) drug abuse Hemoglobin 62 0 Low Labs Hematocrit 63 0 Low Labs Hemoptysis 64 1 Associated admission DX Hemoptysis 64 2 Patient symptoms High Emergency 65 0 Demographics Department Use High Fluid Rates or 66 0 Charted MD orders Volumes (I&O) High Fluid Rates or 67 0 Medications Volumes or Hypertonic Fluids Hx Coronary Artery 68 0 Comorbidities Disease (CAD) Hx Cerebral 69 0 Comorbidities Vascular Accident (CVA) (Stroke) Hx Pulmonary 70 0 Comorbidities Emboli Hx Sepsis 71 0 Comorbidities Insulin-Dependent 72 0 Comorbidities Diabetes Mellitus (IDDM) (aka type 1 diabetes) Interstitial Lung 73 0 Associated Disease admission DX Lactate (elevated) 74 0 Labs Long Term Care 75 0 Demographics (LTC) Resident or Nursing Home Resident Lung abscess 76 0 Associated admission DX Male 77 0 Demographics Morbid Obesity 78 0 Comorbidities Mottling of skin 79 0 Clinical exam Neck Surgery 80 0 Associated admission DX Neuro surgery, 81 0 Associated upper abd. or admission DX Peripheral Vascular Surgery Neuromuscular 82 0 ALS, MS, Stroke, Comorbidities Disease Spinal Cord Injury, Guillain- Barre, myasthenia Gravis New need or greater 83 0 Clinical exam need for assist with ADLS Non-White 84 0 Demographics Opioids 85 0 Medications Orthopnea 86 0 Clinical exam Peripheral edema 87 0 Ankles and legs Clinical exam Pneumonia 88 0 Associated admission DX Pneumothorax 89 0 Associated admission DX Polypharmacy 90 0 Demographics Prior Functional 91 0 Demographics Status Prior Intubation 92 0 Comorbidities Fatigue (acute or 93 0 Patient symptoms profound) Pulmonary Consult 94 0 Charted MD orders Pulmonary Emboli 95 0 Associated admission DX Pulmonary Function 96 0 (One or more Labs Test Abnormals) Pulmonary 97 0 Associated Hypertension admission DX Pulmonary-Renal 98 0 Associated Syndrome admission DX Pulmonary Function 99 0 Charted MD orders Testing Recent 100 0 hospitalization Demographics hospitalization within 90 days Renal Failure 101 0 Associated admission DX Respiratory rate 102 0 Vitals Restlessness 103 0 Patient symptoms Scoliosis 104 0 Comorbidities Sedatives or 105 0 Medications hypnotics or muscle relaxants Sepsis 106 0 Associated admission DX Shock 107 0 cardiogenic, Associated Septic, etc admission DX Sleep Apnea 108 1 Associated admission DX Sleep Apnea 108 2 Comorbidities Smoke Inhalation 109 0 Associated Injury admission DX Smoker 110 0 Comorbidities SpO2 111 0 On Room Air or Vitals decreasing Sputum production 112 1 Clinical exam Sputum production 112 2 Patient symptoms Supplemental O2 or 113 0 Vitals anything other than nasal cannula Surgery including 114 1 Any recent Associated elective surgery surgery admission DX Surgery including 114 2 Any surgery Procedures elective surgery during admission Tachycardia 115 1 Heartrate (HR) > 90 Vitals beats per minute Tachycardia 115 2 Heartrate (HR) > 90 Patient symptoms beats per minute Tachypnea 116 0 Respiration rate Patient symptoms (RR) > 20 or 22 breaths per minute Thoracentesis 117 0 Procedures Transfer from 118 0 Demographics Outside ED Transfer from 119 0 Demographics Higher level of Care Trauma 120 0 Associated admission DX Troponin 121 0 (elevated) Labs VQ Scan or 122 0 (imaging) Charted MD orders Thoracic CT Scan Weight loss 123 0 >10% (six Demographics months) Chronic infectious 124 0 Other disease Lethargy 125 Patient symptoms or Associated admission DX Delirium 126 0 Associated admission DX or Clinical exam or Comorbidities Fluid overload 127 0 Clinical exam or Medications or Labs Abscess 128 0 Associated admission DX Abdominal pain 129 0 Associated admission DX Abdominal 130 0 Associated tenderness admission DX Acute Lung Injury 131 0 Associated admission DX Transfer from ICU 132 0 Demographics Recent, Prior, or 133 0 Medications Acute Antibiotics Appendicitis 134 0 Associated admission DX Asplenic 135 0 Comorbidities Bacteremia 136 0 Associated admission DX Bilirubin 137 0 >/=1.2 mg/dL (or Labs 20 mmol), ALT and AST also elevated Bone marrow 138 0 Comorbidities transplant C-reactive protein 139 0 >2 sd over normal Labs Cardiac Output 140 0 Increased (early) Clinical Exam decreased later as CO drops from volume depletion Cellulitis 141 0 Associated admission DX Cholangitis 142 0 Associated admission DX Cholecystitis 143 0 Associated admission DX Cirrhosis 144 0 Comorbidities Colitis 145 0 Associated admission DX Cystitis 146 0 Associated admission DX D-dimer 147 0 Labs Decrease in daily 148 0 Demographics functions Dehydration 149 0 Associated admission DX Dialysis 150 0 Comorbidities Diverticulitis 151 0 Associated admission DX Diverticulosis 152 0 Comorbidities Early state warm 153 0 Clinical exam and red skin, late state cool and pale w/mottling Encephalitis 154 0 Associated admission DX Encephalopathy 155 0 Associated admission DX Endocarditis 156 0 Associated admission DX Fever 157 0 Clinical exam Fever of unknown 158 0 Associated origin admission DX Gastroenteritis 159 0 Associated admission DX Gastrointestinal 160 0 Associated bleed admission DX Gastrointestinal tract 161 0 Associated infection admission DX Glucose 162 0 Increased (early in Labs diabetic or elevated in non- diabetic) >140 mg/dL Bicarbonate (HCO3) 163 0 Low (early) Labs Headache, Stiff neck 164 0 Clinical exam Heart valve 165 0 (including Comorbidities disorders artificial valves) Hyperlactatemia 166 0 >1 mmol/L Labs Hypothermia 167 0 Clinical exam Hypotension 168 0 Symptom based Associated admission admission DX Ileus 169 0 Clinical exam Immunosuppressants 170 0 Medications Infectious process 171 0 Associated admission DX Inflammatory bowel 172 0 Comorbidities disease International 173 0    >1.5 Labs normalized ratio (INR) for blood clotting Jaundice 174 0 Clinical exam Joint Replacement 175 0 Comorbidities Leukopenia 176 0 Comorbidities Malaise 177 0 Symptom based Associated admission admission DX Malignancy 178 0 Comorbidities Mean arterial 179 0  <70 Vitals pressure Meningitis 180 0 Clinical exam Neoplasm 181 0 Comorbidities Normal white blood 182 0 Labs count (WBC) with >10% neutrophils (bands) Oliguria (decreased 183 0 (<0.5 ml/kg/hr) × Clinical exam or low urine output) 2 hrs or (500 ml/day) Organ transplant 184 0 Comorbidities Osteomyelitis 185 0 Associated admission DX Ostomy 186 0 Associated admission DX PaCO2 187 0  <32 Labs PaO2 188 0 <400 Labs PaO2/FiO2 189 0 <300 Vitals Pelvic pain 190 0 Associated admission DX Peripheral vascular 191 0 Comorbidities disease Peripheral cyanosis 192 0 Clinical exam Petechial rash 193 0 Clinical exam Ph 194 0 Increase early d/t Labs resp alkalosis then decrease later d/t metabolic acidosis Platelets 195 0 <150 Labs Positive fluid 196 0 >20 ml/kf ocwe Clinical exam balance 24 hours Pre-existing or 197 0 Associated current renal disease admission DX or Comorbidities Pressure injury 198 0 Comorbidities Procalcitonin 199 0 Elevated >2 sd Labs over normal Protein in urine 200 0 Azotemia Labs Partial 201 0 >60 s Labs thromboplastin time (PTT) Pyelonephritis 202 0 Associated admission DX Recent abortion 203 0 Comorbidities Recent childbirth 204 0 Comorbidities Recent surgery 205 0 Demographic (including dental) Respiratory 206 0 Associated infection admission DX Seizures 207 0 Clinical exam or comorbidities Septic arthritis 208 0 Associated admission DX Sickle cell anemia 209 0 Comorbidities Soft tissue infection 210 0 Associated admission DX Stupor 211 0 Clinical exam Surgical admission 212 0 Associated admission DX Syncope (fainting) 213 0 Other Systolic blood 214 0 <100 or change Vitals pressure (SBP) from baseline SBP drop 40 pt from baseline Temperature 215 0 >38° Celsius (C.) Vitals or <36° C. Terminal illness 216 0 Any Comorbidities Volume depletion 217 0 Nausea, vomiting, Clinical exam diarrhea White blood cell 218 0 <4000 or >12000 Labs count Wound 219 0 Associated admission DX Acute respiratory 220 0 Associated distress syndrome admission DX

(78) It should be noted that some risk factors in Table 1 appear twice but are designated in a separate column as either risk factor identification (rfid) type (rfid_type) 1 or rfid_type 2, with the others having rfid_type 0. The two different types of risk factors mean, for example, that there are multiple sources from which the risk factor may be obtained or, in some instances, that the risk factor is based on gender (e.g., male or female). One or more of the risk factors in Table 1 are selectable in a spread sheet to set up a risk rule that is implemented by the analytics engine 20 in system 10. An example of such risk rules that may be established include determining with the analytics engine 20 that the patient may be at risk of developing respiratory distress if any of the following conditions are met: (1) the patient is 70 years of age or older and has COPD; (2) the patient has COPD and has been prescribed opioids; (3) the patient is 70 years of age or older and has been prescribed opioids; (4) the patient is 70 years of age or older, has asthma, and has a blood urea nitrogen (BUN) of greater than or equal to 30 milligrams (mg) per 100 milliliters (ml) of blood; or (5) any four of the patient conditions listed in Table 1 are present. Further examples of such risk rules that may be established include determining with the analytics engine 20 that the patient may be at risk of developing sepsis if any of the following conditions are met: (1) the patient is 65 years of age or older and has cancer; or (2) the patient has a history of developing sepsis.

(79) It is within the scope of the present disclosure for risk rules to be established based on any number of the risk factors set forth in Table 1 and, with regard to those risk factors that pertain to dynamically measurable parameters such as patient physiological parameters (e.g., those indicated at Vitals in the Type column of Table 1), the risk rules can be based on the particular measurable parameter being above or below a threshold criteria. Thus, the present disclosure contemplates that assessing medical risks of a patient includes receiving at the analytics engine 20 patient demographics data of the patient including, for example, at least one of age, race, and weight as shown in Table 1. The analytics engine 20 also receives comorbidity data of the patient in some embodiments including data indicating that the patient has at least one of the following medical conditions or characteristics: acquired immunodeficiency syndrome (AIDS), anemia, chronic congestive heart failure, asthma, cancer, chronic obstructive pulmonary disease (COPD), coronary artery disease, cystic fibrosis, dementia, emphysema, alcohol or drug abuse, stroke, pulmonary emboli, a history of sepsis, type 1 diabetes, morbid obesity, neuromuscular disease, prior intubation, scoliosis, smoker, delirium, asplenic, bone marrow transplant, cirrhosis, dialysis, diverticulosis, heart valve disorders, inflammatory bowel disease, joint replacement, leukopenia, malignancy, neoplasm, organ transplant, peripheral vascular disease, renal disease, pressure injury, recent abortion, recent childbirth, seizures, sickle cell anemia, or terminal illness.

(80) In some embodiments, the analytics engine 20 also receives physiological data that may be measured by a physiological monitor that may have at least one sensor coupled to, or in communication with, the patient. The physiological data includes data that is dynamic and changing over time while the patient is being monitored by the physiological monitor. For example, the physiological data includes one or more of the following: heartrate, respiration rate, temperature, mean arterial pressure, systolic blood pressure, or pulse oximetry data including peripheral capillary oxygen saturation (SpO2). In some embodiments, the analytics engine 20 calculates a risk score or performs a risk assessment of the patient in substantially real time based on one or more of the patient demographics data, the comorbidity data, and the physiological data.

(81) The analytics engine 20 also receives laboratory data of the patient in some embodiments and uses the laboratory data in connection with calculating the risk score. As shown in Table 1, examples of the laboratory data includes data that pertains to one or more of the following: albumin, arterial partial pressure of oxygen (arterial PaO2), arterial partial pressure of carbon dioxide (PCO2), arterial pH, acidosis, brain natriuretic peptide, blood urea nitrogen, cardiac ejection fraction, creatinine, hemoglobin, hematocrit, lactate, pulmonary function test, troponin, bilirubin, C-reactive protein, D-dimer, glucose, bicarbonate (HCO3), hyperlactatemia, international normalization ratio (INR) for blood clotting, normal white blood count (WBC) with greater than 10% neutrophils, arterial partial pressure of carbon dioxide (PaCO2), fluid overload, Ph, platelets, procalcitonin, protein in urine, partial thromboplastin time (PTT) or white blood cell count. Alternatively or additionally, the analytics engine 20 receives patient symptoms data of the patient and uses the patient symptoms data in connection with calculating the risk score. As shown in Table 1, examples of the patient symptoms data includes data that pertains to one or more of the following: accessory muscle use, altered mental status, confusion, anxiety, chest pain, cough, cyanosis, diaphoresis, dyspnea, hemoptysis, fatigue, restlessness, sputum production, tachycardia, tachypnea, or lethargy.

(82) Further alternatively or additionally, the analytics engine 20 receives clinical examination data and uses the clinical examination data in connection with calculating the risk score. As shown in Table 1, examples of the clinical examination data includes data pertaining to one or more of the following: abdominal respirations, abnormal lung sounds, accessory muscle use, capillary refill, chest pressure or pain, abnormal electrocardiograph (ECG or EKG), cough, cyanosis, decreased level of consciousness (LOC), agitation, encephalopathy, mottling, need for assistance with activities of daily living (ADLS), orthopnea, peripheral edema, sputum production, delirium, fluid overload, cardiac output, early state warm red skin and late state cool and pale with mottling, fever, headache, stiff neck, hypothermia, ileus, jaundice, meningitis, oliguria, peripheral cyanosis, petechial rash, positive fluid balance, seizures, stupor, or volume depletion.

(83) Still further alternatively or additionally, the analytics engine 20 receives charted doctor's orders data and uses the charted doctor's order data in connection with calculating the risk score. As shown in Table 1, examples of the charted doctor's orders data includes data that pertains to one or more of the following: delivery of breathing air other than with a cannula including with a Venturi, a rebreather, a non-rebreather, a continuous positive airway pressure (CPAP) machine, and a bi-level positive airway pressure (bi-PAP) machine; testing of arterial blood gases; testing of brain natriuretic peptide; breathing treatments; chest x-ray; Doppler echocardiography; high fluid rates or volumes (input and output (I&O)); pulmonary consultation; pulmonary function testing; ventilation-perfusion (VQ) scan; or thoracic computerized tomography (CT) scan.

(84) In some embodiments, the analytics engine 20 also receives admission data for the patient and uses the admission data in connection with calculating the risk score. As shown in Table 1, examples of the admission data includes data that pertains to one or more of the following: abdominal aortic aneurysm surgery, acute myocardial ischemia, acute pancreatitis, aspiration, asthma, bronchiectasis, atelectasis, bronchitis, burns, cancer, cardiac or thoracic surgery, cardiac valve disorder or valvular insufficiency, chemo therapy, congestive heart failure, COPD exacerbation, deep vein thrombosis, drug overdose, dyspnea at rest, emergency surgery, hemoptysis, interstitial lung disease, lung abscess, neck surgery, neuro surgery, upper abdomen surgery, peripheral vascular surgery, pneumonia, pneumothorax, pulmonary emboli, pulmonary hypertension, pulmonary-renal syndrome, renal failure, sepsis, shock, sleep apnea, smoke inhalation injury, surgery, thoracentesis, trauma, lethargy, delirium, abscess, abdominal pain, abdominal tenderness, acute lung injury, appendicitis, bacteremia, cellulitis, cholangitis, cholecystitis, colitis, cystitis, dehydration, diverticulitis, encephalitis, encephalopathy, endocarditis, fever of unknown origin, gastroenteritis, gastrointestinal bleed, gastrointestinal tract infection, hypotension, infectious process, malaise, osteomyelitis, ostomy, pelvic pain, renal disease, pyelonephritis, respiratory infection, septic arthritis, soft tissue infection, surgical admission, wound, or acute respiratory distress syndrome.

(85) Alternatively or additionally, the analytics engine 20 receives medications data for the patient and uses the medications data in connection with calculating the risk score. As shown in Table 1, examples of the medications data includes data that pertains to one or more of the following: anticoagulants including heparin or levenox that may be delivered intravenously (IV) or subcutaneously (SC), bronchodilators, corticosteroids, diuretic use, high fluid rates or volumes or hypertonic fluids, opioids, sedatives, hypnotics, muscle relaxants, fluid overload, antibiotics, or immunosuppressants.

(86) Based on the forgoing, it should be appreciated that the present disclosure contemplates a method implemented on at least one computer such one or more of analytics engine 20 and other servers such as servers 62, 210, 212, 206. In the discussion that follows, it will be assumed that analytics engine 20 implements the various algorithms and functions. According to the method, the analytics engine 20 receives dynamic clinical variables and vital signs information of a patient. The analytics engine 20 uses the vital signs information to develop prior vital signs patterns and current vital signs patterns and then compares the prior vital signs patterns with the current vital signs patterns. The analytics engine 20 also receives one or more of the following: static variables of the patient, subjective complaints of the patient, prior healthcare utilization patterns of the patient, or social determinants of health data of the patient. The analytics engine 20 uses the dynamic clinical variables, the vital signs information, the results of the comparison of the prior vital signs patterns with the current vital signs patterns, and the one or more of the static variables, the subjective complaints, the healthcare utilization patterns, or the social determinants of health data in an algorithm to detect or predict that the patient has sepsis or is likely to develop sepsis.

(87) In some embodiments, the dynamic clinical variables received by the analytics engine 20 includes point-of-care lab data. Optionally, the static variables received by the analytics engine 20 includes comorbidities. Alternatively or additionally, the static variables received by the analytics engine 20 includes whether the care setting of the patient is a pre-acute care setting, an acute care setting, or a post-acute care setting. If desired, the analytics engine 20 also receives historical data of the patient.

(88) It is within the scope of the present disclosure for the analytics engine 20 to output one or more recommended actions to one or more clinicians of each of the patients being monitored. Examples of the one or more recommended actions include, for example, sending the patient to an emergency department (ED), increasing monitoring of the patient by the one or more clinicians, or ordering a set of labs for the patient.

(89) In some embodiments, the analytics engine 20 ranks the clinicians of a healthcare facility. For example, the analytics engine 20 ranks the clinicians of the healthcare facility by one or more of experience, actions previously taken, and prior patient outcomes. Optionally, the actions that have greatest impact on outcomes may be used by the analytics engine 20 to inform newer or less experienced clinicians how an experienced clinician may attend to the patient.

(90) It is contemplated by the present disclosure that artificial intelligence (AI) and machine learning is used by the analytics engine 20 to analyze risk factor data of the type listed in Table 1 and to determine correlations between one or more of the risk factors and particular risks such as pressure injuries, falls, and sepsis, as well as other risks for patients. Risk factors that are highly correlated to particular risks are then used to established risk rules based on two or more of the highly-correlative risk factors.

(91) As discussed above in connection with FIGS. 3 and 6, mobile devices 60 of caregivers are among the output devices 34 on which risk scores and risk data are displayed. FIGS. 7-10 show screen shot examples of the type of information displayed on mobile devices 60 of caregivers. The examples of FIGS. 7-10, in some embodiments, are contemplated as being provided by additional software functionality of the LINQ™ mobile application available from Hill-Rom Company, Inc. Additional details of the LINQ™ mobile application can be found in U.S. application Ser. No. 16/143,971, filed Sep. 27, 2018, titled “Caregiver and Staff Information System,” published as U.S. Patent Application Publication No. 2019/0108908 A1, and which is hereby incorporated by reference herein.

(92) Referring now to FIG. 7, an example of a Patient screen 220 of a mobile application displayed on a touch screen display of mobile devices 60 of FIGS. 3 and 6 includes a My Patients button or icon 222 and a My Unit 224 button or icon near the top of screen 220. In the illustrative example, the My Patients icon 222 has been selected and, as a result, screen 220 includes a list 226 of the patients assigned to the caregiver of the mobile device 60 on which screen 220 is shown. Each of the caregiver's assigned patient's is shown in a separate row of the list 226 and includes the patient's name and the room in the healthcare facility to which the patient has been assigned. Beneath each of the patient's room number and name, one or more risk scores and associated information is shown, when applicable. If the My Unit button 224 is selected, then similar information is shown on the display screen of the mobile device 60 for all patients in the unit of the healthcare facility to which the caregiver is assigned, including patients assigned to other caregivers of the unit.

(93) In the illustrative example of screen 220 in FIG. 7, beneath the text “2160 HILL, LARRY” in the first line of list 226, a first risk score box 228 shows a systemic inflammatory response syndrome (SIRS) score having a value of 4 and a second risk score box 230 shows a modified early warning score (MEWS) scored having a value of 5. Also in the illustrative example, an up arrow icon 232 is shown to the left of each of boxes 228, 230 in the first row of list 226 to indicate that the SIRS and MEWS scores have both increased as compared to their prior readings. In the illustrative example, “@ 9:20” appears to the right of the text “MEWS” in the first row of list to indicate the time that the MEWS score was most recently updated. In rows two through four of the illustrative example of list 226, only box 230 is shown with the MEWS score for the respective patient. The fifth row of list 226 has the text “2159 NO PATIENT” to indicate that room 2159 does not currently have any patient assigned to it, but if there was a patient assigned to room 2159, then that patient would be among the patients assigned to the caregiver of the mobile device 60 on which screen 220 is shown. Screen 220 also has a menu 234 of icons or buttons (these terms are used interchangeable herein) which is beneath list 226 and which includes a Home icon 236, a Contacts icon 238, a Messages icon 240, a Patients icon 242 and a Phone icon 244. Additional details of the screens and functions associated with icons 236, 238, 240, 242, 244 can be found in U.S. application Ser. No. 16/143,971, filed Sep. 27, 2018, published as U.S. Patent Application Publication No. 2019/0108908 A1, and which is already incorporated by reference herein.

(94) Referring now to FIG. 8, an example is shown of a Risk Details screen 250 that appears on the touchscreen display of the caregiver's mobile device 60 in response to selection of one of the right arrow icons 252 of screen 220 at the right side of each row of list 226. In the illustrative example of FIG. 8, screen 250 shows risk details for patient Larry Hill as indicated at the top of screen 250. A left arrow icon 254 is provided to the left of the text “PATIENTS 2160 HILL, L.” at the top of screen 250 and is selectable to return the caregiver back to screen 220. In the illustrative example of screen 250, phone icon 244 no longer appears in menu 234 but rather appears at the top right of screen 250. The other icons 236, 238, 240, 242 remain in menu 234 at the bottom of screen 250.

(95) Still near the top of screen 250, the patient's medical record number (MRN) is shown in field 256 and the patient's age is shown in field 258. In the illustrative example, the patient's MRN is 176290 and the patient is 76 years old. Beneath field 256 of screen 250, three status icons are shown. In particular, a falls risk icon 260, a pulmonary risk icon 262, and a pressure injury icon 264 is shown. If the patient is determined to be at risk of falling, then icon 260 is highlighted. If the patient is determined to be at risk for respiratory distress, then icon 262 is highlighted. If the patient is determined to be at risk of developing a pressure injury, then icon 264 is highlighted. Icons 260, 262, 264 are grayed out or are absent if the corresponding patient is determined not to have the associated risk.

(96) With continued reference to FIG. 8, a MEWS window 266 is shown beneath icons 260, 262, 264 and has additional information pertaining to the MEWS score appearing in box 230. Box 230 and up arrow icon 232 appear at the left side of window 266. To the right of box 230 and icon 232 in window 266, various vital signs information that relate to or contribute to the MEWS score are shown. In the illustrative example of screen 250, the patient, Larry Hill, has a temperature of 100.6° Fahrenheit (F), an SPO2 of 92%, a non-invasive blood pressure (NIBP) of 200/96 mmHg, a heart rate (HR) of 118 beats per minute (BPM), and a respiration rate (RR) of 26 breaths per minute (BPM). Up arrow icons 267 appear in window 266 to the right of any of the vital signs that have increased since the prior reading.

(97) According to this disclosure, the data needed to calculate the MEWS is obtained from sensors included as part of medical devices 12 such as patient beds 14 and vital signs monitors 18, and/or is received as manual user inputs based on clinical insights 24 of caregivers, and/or obtained from the person's EMR of EMR server 62. The MEWS is a known score calculated based on the following table:

(98) TABLE-US-00002 TABLE 2 Score 3 2 1 0 1 2 3 Systolic BP <70 71-80  81-100 101-199 — >200   — Heart rate (BPM) — <40 41-50  51-100 101-110 111-129 >130 Respiratory rate (RPM) —  <9 —  9-14 15-20 21-29  >30 Temperature (° C.) — <35 — 35.0-38.4 — >38.5 — AVPU — — — A V P U

(99) In Table 2, the various integers in the column headings are added together based on the various readings for the person of the data corresponding to the rows of the table. A score of 5 or greater indicates a likelihood of death. With regard to the systolic blood pressure, heart rate, respiratory rate, and temperature portions of the MEWS, those pieces of information are obtained using sensors of patient beds 14 and/or using the other manners of obtaining a person's physiological data as discussed above. The AVPU portion of the MEWS indicates whether a person is alert (A), responsive to voice (V), responsive to pain (P), or unresponsive (U). A caregiver selects the appropriate AVPU letter for each patient and enters it into a computer such as room station 50, their mobile device 60, or another computer of system 10 such as a nurse call computer, an EMR computer, an ADT computer, or the like.

(100) Still referring to screen 250 of FIG. 8, a Sepsis-Related Organ Failure Assessment (SOFA) window 268 is shown beneath window 266 and has information pertaining to a SOFA score. At the left side of window 268 a risk score box 270 shows the SOFA score value, 2 in the illustrative example, and an up arrow icon 272 indicates that the SOFA score has increased as compared to the previous score. To the right of box 270 and icon 272 in window 268, the patient's physiological parameters that contribute or relate to the SOFA score are shown. In the illustrative example, the patient has platelets of 145 per microliter (μL), an output/input of 800 milliliters per day, and a cardiovascular (CV) of 58 mean arterial pressure (MAP).

(101) A MORSE window 274 having information pertaining to a MORSE Fall Scale (MFS) score or value is shown on screen 250 of FIG. 8 beneath window 268. At the left side of window 274 a risk score box 276 shows the MORSE or MFS score value, 3 in the illustrative example. There is no up arrow icon or down arrow icon shown next to box 276 thereby indicating that the MORSE score has not changed since the previous reading. To the right of box 276 are risk factors that contribute or relate to the MORSE score. In the illustrative example, the patient's mobility risk factors include the patient being vision impaired and having a hip replacement and the patient's medications risk factors include that the patient is prescribed a sedative. In each of windows 266, 268, 274, the time at which the score in the respective risk score box 230, 270, 276 was most recently updated is indicated beneath the respective box 230, 270, 276.

(102) As shown in FIG. 8, screen 250 includes a pair of Risk Contributors windows including a respiratory distress window 278 listing factors contributing or relating to a risk that the patient will experience respiratory distress and a sepsis window 280 listing factors contributing or relating to the patient's risk of developing sepsis. In the illustrative example, the risk factors in respiratory distress window 278 include the patient having chronic obstructive pulmonary disease (COPD), the patient being over 65 years of age, and the patient being a smoker, and the risk factors in the sepsis window 280 include the patient having a urinary tract infection (UTI) and the patient being over 65 years of age. The example of FIG. 8 demonstrates that patient risk factors can be used in connection with multiple risk scores or risk contributors to the risk scores or risk determinations.

(103) With regard to windows 266, 268, 274, some or all of these are color coded in some embodiments to indicate the severity level of the particular risk score or the particular risk factors relating to the risk scores or determinations. For example, the area around box 230 of window 266 and the border of window 266 is color coded red if the risk value in box 230 is 5 or greater to indicate that the patient is at a high amount of risk. Similarly, the area around boxes 270, 276 of windows 268, 274, respectively, is color coded yellow if the risk values in boxes 270, 276 indicate a medium amount of risk, as is the case in the illustrative example. The arrows 232, 267, 272 are also color coded in some embodiments, typically with a darker shade of red or yellow, as the case may be. If the risk score for any particular risk factor indicates a low level of risk, then the associated window on screen 250 is color coded green or some other color such as blue or black. Risk contributors windows 278, 280 are similarly color coded (e.g., red, yellow, green) in some embodiments, depending upon the number or severity of risk factors that are present for the particular patient. The individual numerical data or risk factors in windows 266, 268, 274 are also color coded in some embodiments.

(104) Referring now to FIG. 9, an example is shown of an alternative Risk Details screen 250′ that appears on the touchscreen display of the caregiver's mobile device 60 in response to selection of one of the right arrow icons 252 of screen 220 at the right side of each row of list 226 of FIG. 7. Portions of screen 250′ that are substantially the same as like portions of screen 250 are indicated with like references and the description above of these portions of screen 250 is equally applicable to screen 250′. In the illustrative example of FIG. 9, screen 250′ shows risk details for patient Larry Hill as indicated at the top of screen 250′ Beneath the MRN data 256 and age data 258 of screen 250′ is a MEWS window 282. At the right side of window 282, the MEWS score box 230 and up arrow icon 232 is shown.

(105) Window 282 includes a temperature score box 284, a respiration rate (RR) score box 286, a level of consciousness (LOC) score box 288, a first custom score box 290, and a second custom score box 292 as shown in FIG. 9. In the illustrative example, boxes 284, 286 each have a score of 2 and box 288 has the letter P from the AVPU score shown above in Table 2. Illustrative MEWS box 230 has a score of 5 in the illustrative example of screen 250′ in FIG. 9, but really, the score should be shown as 6 assuming that the P in box 288 corresponds to a score of 2 as shown in Table 2. In the illustrative example of screen 250′ up arrow icons 294 are shown beneath boxes 284, 288 to indicate that the temperature portion and the LOC portion, respectively, of the MEWS have each increased since the previous values used to calculate the previous MEWS. A dash icon 296 is shown in window 282 beneath box 286 to indicate that the patient's RR portion of the MEWS has not changed since the previous MEWS calculation.

(106) The custom score boxes 290, 292 of window 282 indicate that a revised MEWS or amended MEWS is within the scope of the present disclosure. Thus, designers or programmers of system 10 for any given healthcare facility are able to pick other risk factors, such as those shown above in Table 1, that contribute to such a revised or amended MEWS. Just to give one example, age could be the risk factor chosen as corresponding to one of the boxes 290, 292. The score values based on age ranges are also at the discretion of the system designer or programmer. Thus, integers between 0 and 3 could be assigned to different age ranges just to give one arbitrary example (e.g., 20 year of age or younger=0; 21-40 years of age=1; 41-60 years of age=2; 61 years of age or older=3). Optionally, negative numbers for certain age ranges could be used. For example, 20 years of age or younger could be assigned an age score of −1 which would result in the illustrative score of 5 for such an amended MEWS score assuming the patient associated with window 282 is 20 years of age or younger (i.e., boxes 284, 286, 288 would add up to 6 and then with the −1 age score, the overall amended MEWS would be 5). Again, this is just an arbitrary example and it should be appreciated that there are practically limitless possibilities of risk factors from Table 1 and numerical score scenarios that could be chosen in connection with custom boxes 290, 292 of window 282 to create a revised or amended MEWS.

(107) Still referring to screen 250′ of FIG. 9, a systemic inflammatory response syndrome (SIRS) window 298 is shown beneath window 282. A SIRS score box 300 is shown at the right side of window 298 and a check mark 302 appears in box 300 to indicate that the patient is positive for SIRS. If the patient is negative for SIRS, then box 300 is blank. In the left side of window 298, the risk factors and associated data that have contributed or that relate to the positive SIRS determination for the patient are shown. In the illustrative example of screen 250′, window 298 includes heart rate (HR) data of 118 beats per minute and a white blood count (WBC) less than 4,000. In some embodiments, the determination as whether or not the patient is positive for SIRS is based on the following table:

(108) TABLE-US-00003 TABLE 3 Systemic inflammatory response syndrome (SIRS) Finding Value Temperature <36° C. (98.6° F.) or >38° C. (100.4° F.) Heart rate >90/min Respiratory >20/min or PaCO2 < 32 mmHg (4.3 kPa) rate WBC <4 × 10.sup.9/L (<4000/mm.sup.3), >12 × 10.sup.9/L (>12,000/mm.sup.3), or 10% bands

(109) In typical embodiments, if any two or more conditions indicated in the rows of table 3 is met, then the patient is considered to be positive for SIRS. In other embodiments, at the discretion of the system designer or programmer, two, three, or all four of the conditions indicate in table 3 need to be met before a patient is considered to be positive for SIRS. The present disclosure also contemplates that additional patient risk factors, such as those listed above in table 1, are used in connection with assessing patients for SIRS. It should be appreciated that there are practically limitless possibilities of risk factors from Table 1 and numerical score scenarios that could be chosen in connection with adding additional rows to table 3 or replacing one or more of the current rows of table 3 to create the criteria for the revised or amended SIRS assessment.

(110) Some other factors that are commonly used in connection with a SIRS determination include suspected or present source of infection (SIRS+source of infection), severe sepsis criteria (organ dysfunction, hypotension, or hypoperfusion) indicated by lactic acidosis or SBP<90 or SBP drop ≥40 mmHg of normal, and evidence of ≥2 organs failing (multiple organ dysfunction syndrome criteria), just to name a few. In any event the SIRS value is sometimes displayed on mobile devices 60 as a numerical score indicating the number of SIRS risk factors that are met, and sometimes is displayed as a check mark that indicates that patient is considered to be positive for SIRS.

(111) With continued reference to screen 250′ of FIG. 9, a Sepsis-Related Organ Failure Assessment (SOFA) window 304 is shown beneath window 298. At the right side of window 304, the SOFA score box 270 and up arrow icon 272 is shown. These are basically the same as shown in window 268 of FIG. 8 and so the same reference numbers are used. However, unlike window 268 of screen 250 which shows numerical data for the risk factors that contribute to the SOFA score, window 304 of screen 250′ has risk score boxes for each of the contributing risk factors. In the illustrative example, a platelets risk score box 306 and a cardiovascular risk score box 308 is shown in window 304 and each box 306, 308 has a score of 1 which, when added together, results in the overall SOFA risk score of 2 shown in box 270 of window 304.

(112) In some embodiments of system 10, a quick SOFA (qSOFA) score is also determined and shown on the mobile devices 60 of caregivers. The qSOFA score may be shown in lieu of or in addition to the SOFA score. The following table 4 is used in connection with calculating the qSOFA score in some embodiments:

(113) TABLE-US-00004 TABLE 4 Assessment qSOFA score Low blood pressure (SBP ≤ 100 mmHg) 1 High respiratory rate (≥22 breaths/min) 1 Altered mentation (GCS ≤ 14) 1
In some embodiments, one or more of the following tables are used in connection with calculating the SOFA score:

(114) TABLE-US-00005 TABLE 5 Respiratory system PaO.sub.2/FiO.sub.2 (mmHg) SOFA score ≥400 0 <400 +1 <300 +2 <200 and mechanically ventilated +3 <100 and mechanically ventilated +4

(115) TABLE-US-00006 TABLE 6 Nervous system Glasgow coma scale SOFA score 15 0 13-14 +1 10-12 +2 6-9 +3 <6 +4

(116) TABLE-US-00007 TABLE 7 Cardiovascular system Mean arterial pressure OR administration of vasopressors required SOFA score MAP ≥ 70 mmHg 0 MAP < 70 mmHg +1 dopamine ≤ 5 μg/kg/min or dobutamine (any dose) +2 dopamine > 5 μg/kg/min OR epinephrine ≤ 0.1 +3 μg/kg/min OR norepinephrine ≤ 0.1 μg/kg/min dopamine > 15 μg/kg/min OR epinephrine > 0.1 +4 μg/kg/min OR norepinephrine > 0.1 μg/kg/min

(117) TABLE-US-00008 TABLE 8 Liver Bilirubin (mg/db) [μmol/L] SOFA score <1.2 [<20] 0 1.2-1.9 [20-32] +1 2.0-5.9 [33-101] +2 6.0-11.9 [102-204] +3 >12.0 [>204] +4

(118) TABLE-US-00009 TABLE 9 Coagulation Platelets.sup.×10.sup.3/μl SOFA score ≥150 0 <150 +1 <100 +2 <50 +3 <20 +4

(119) TABLE-US-00010 TABLE 10 Kidneys Creatinine (mg/dl) [μmol/L] (or urine output) SOFA score <1.2 [<110] 0 1.2-1.9 [110-170] +1 2.0-3.4 [171-299] +2 3.5-4.9 [300-440] (or <500 ml/d) +3 >5.0 [>440] (or <200 ml/d) +4
To calculate the overall qSOFA score, the score values in the right hand column of table 4 or, with regard to the SOFA score, the right hand column of whichever of tables 5-10 are being used in connection with the SOFA score, are added together. In the illustrative example of window 304, an up arrow icon 310 is shown beneath box 306 to indicate that the patient's platelets have increased since the previous platelets reading and a dash icon 312 is shown beneath box 308 to indicate that the patient's cardiovascular reading has not changed since the prior cardiovascular reading.

(120) Screen 250′ of FIG. 9 also has respiratory distress window 278 and sepsis window 280 which are basically the same as windows 278, 280 of screen 250 of FIG. 8 and so the same reference numbers are used. However, in addition to text indicating that the patient has COPD, is older than 65 years of age, and is a smoker, window 278 of FIG. 9 also indicates that the patient has a respiration rate less than 15 breaths per minute. Also, in addition to text indicating that the patient has a UTI and is older than 65 years of age, window 280 of FIG. 9 also indicates that the patient has a WBC less than 4,000. Similar to the color coding discussed above in connection with windows 266, 268, 274, 278, 280 of screen 250 of FIG. 8 and the information therein, windows 278, 280, 282, 298, 304 of screen 250′ of FIG. 9 can be similarly color coded in some embodiments.

(121) Referring now to FIG. 10, an example is shown of a MEWS Details screen 320 that provides greater details relating to the MEWS of screens 250, 250′ of FIGS. 8 and 9. Thus, if the caregiver touches, taps, or swipes MEWS window 230 of screen 250 or MEWS window 282 of screen 250′, then screen 320 appears on the touchscreen display of the caregiver's mobile device 60. Portions of screen 320 that are substantially the same as like portions of screens 220, 250, 250′ of FIGS. 7-9, respectively, are indicated with like reference numbers and the description above is equally applicable to screen 320 with regard to the like portions.

(122) Screen 320 has an expanded MEWS data window 322 beneath the MRN data 256 and age data 258. In the illustrative example, the SIRS and SOFA windows 298, 304 of screen 250′ of FIG. 9 are minimized into smaller windows 298′,304′, respectively, beneath expanded MEWS data window 322. Windows 298′,304′ omit the risk factor data shown, for example, in windows 298, 304. However, windows 298′,304′ still show boxes 272, 300 with the respective SOFA score and SIRS check mark icon 302. The up arrow icon 272 is also still shown in window 304′. The expanded MEWS data window 322 includes the boxes 230, 284, 286, 288 that were shown in window 282, but the positions of these boxes has been rearranged and several other boxes, along with numerical data, are also shown in window 322. Up arrow icons 232, 294 are also shown in window 322 to the right of boxes 230, 284, respectively. In the illustrative example of screen 320, an up arrow icon 324 is shown to the right of box 286 and a dash icon 326 is shown to the right of box 288 in window 322.

(123) Window 322 also includes a noninvasive blood pressure (NIBP)—systolic risk score box 328, an SPO2 risk score box 330, an NIBP—diastolic risk score box 332, and a pulse rate risk box 334. In the illustrative example, each of boxes 328, 330, 332 has an “X” to indicate that the numerical values of the associated patient physiological parameters do not contribute to the overall MEWS for the patient. In other embodiments, “0” appears in the respective boxes when the associated risk factor does not contribute to the MEWS of the patient. In the illustrative example, a risk score value of 2 appears in box 334. Dash icons 326 are shown to the right of each of boxes 328, 339, 332, 334 to indicate that the respective readings have not changed since the prior readings. The values in boxes 284, 286, 288, 328, 330, 332, 334 of window 322 are sub-scores that, when added together, provide the overall MEWS score for the patient. As noted above, risk factors from table 1 can be used to create a revised or amended MEWS (aka a customized MEWS) and in such instances, the selected risk factors from table 1 have associated risk score boxes and risk data in window 322. Similarly, relevant risk score boxes and data are also shown if windows 268, 264 of screen 250 of FIG. 8 or if windows 298, 304 of screen 250′ of FIG. 9 are selected on the caregiver's mobile device 60 rather than window 266 of screen 250 or window 282 of screen 250′.

(124) According to the present disclosure, an EMR plug-in in the form of a software module is provided in system 10 in some embodiments. The EMR plug-in is used by hospital administrators and caregivers to view a patient's deterioration (e.g., development of sepsis, respiratory distress, pressure injury, etc.) and falls risks giving users dynamic risk monitoring allowing earlier and more consistent identification of patient risk. The plug-in provides viewing of the risk scoring with additional context beyond conventional early warning scores (EWS's) and builds caregiver trust by providing criteria and reasoning behind the risk scoring. The EMR plug-in also indicates if there are missing parameters in a patient's deterioration risk score(s) on an ongoing basis so caregivers are informed of which risk parameters still need to be assessed and entered.

(125) In some embodiments, the EMR plug-in is accessed via navigation in an EMR computer that is in communication with EMR server 62. The EMR computer launches a webpage provided by the EMR plug-in. The EMR plug-in is configured to assist in reducing/eliminating delays and communication shortcomings between care personnel/teams during an escalation event or handoff. A Situation, Background, Assessment, Recommendation (SBAR) feature is provided in the EMR plug-in and ensures that a patient's deterioration risk is promptly communicated to the appropriate caregivers upon a hand-off or escalation event to facilitate an efficient transfer of knowledge of the patient's deterioration risk.

(126) With regard to calculating a falls risk score according to the present disclosure, additional details can be found in U.S. Provisional Patent Application No. 62/818,828, which was filed Mar. 15, 2019, and which is titled “Patient Fall Likelihood,” and in U.S. Provisional Patent Application No. 62/818,836, which was also filed on Mar. 15, 2019, which is titled “Patient Fall Likelihood and Severity,” and both of which are hereby incorporated by reference herein in their entirety to the extent not inconsistent with the present disclosure which shall control as to any inconsistencies. According to these two provisional patent applications, a falls risk score (or just, fall score) is determined based on the following formula:
fall score=immediate risk model score+attribute risk model score

(127) The immediate risk model score is based on the following formula:
immediate risk model score=data1×weight1+data2×weight2+. . . dataN×weightN
where the data can include activity at a given period of time (e.g., toileting during sleeping hours), a medication change, acute motion detected for the patient, etc. Thus, the immediate risk model score is a numerical quantification of the likelihood of an immediate fall with each relevant piece of data weighted and added to create the score. For example, the acute movement of the patient can be weighted more highly than change in medication.

(128) The attribute risk model score is based on the following formula:
attribute risk model score=data1×weight1+data2×weight2+ . . . dataN×weightN
where the data can include bibliographic/demographic information associated with the patient, such as history of falling, age, frequency or urgency of urination, type of medication taken, procedures under which the patient has gone, a gait analysis, etc. Thus, the attribute risk model score is a numerical quantification of the likelihood of a fall based on attributes of the patient collected over time with each relevant piece of data weighted and added to create the score. For example, the poor gait of the patient can be weighted more highly than motion of the patient in bed over time.

(129) With regard to specific devices for detecting and monitoring sepsis according to the present disclosure, additional details can be found in U.S. Provisional Patent Application No. 62/825,844 (“the '844 application), filed Mar. 29, 2019, titled “Sepsis Detection and Monitoring,” and which is hereby incorporated by reference herein in its entirety to the extent not inconsistent with the present disclosure which shall control as to any inconsistencies. The devices disclosed in the '844 application provide further examples of the type of medical devices 14 of system 10 that provide data to analytics engine 20. For example, the '844 application contemplates that an ECG or photoplethysmogram (PPG) or radar transmitter/receiver can detect heart rate variability of a patient and if the heart variability decreases, which is an indicator of the onset sepsis, the rate of acquiring vital signs data is increased. The '844 application incorporates by reference U.S. Provisional Patent Application No. 62/798,124, filed Jan. 29, 2019, for its disclosure of monitoring devices that use radar signals. Thus, U.S. Provisional Patent Application No. 62/798,124, filed Jan. 29, 2019, is hereby incorporated by reference herein, as well, in its entirety for the same purpose.

(130) Further according to the '844 application, a fundus imaging system including a camera is used to capture images of the fundus (e.g., the retina, optic nerve, macula, vitreous, choroid and posterior pole) of a patient during a full cardiac cycle. The images are analyzed to determine whether the patient has microvascular dysregulation which is another indicator of the onset or existence of sepsis in the patient. The fundus imaging system can also be configured to measure the patient's flicker response by exposing the patient's retina to a flashing light and then measuring the reactivity of the retinal blood vessels which is diminished in septic patients due to neurovascular decoupling. Still further, the fundus imaging system can be configured to measure local oxygenation of the retina in connection with determining whether the patient has sepsis. The fundus imaging system can also be configured to measure blood flow velocity changes to detect that the patient is septic because blood vessel walls become “sticky” and blood cells become rigid causing sluggish blood flow in septic patients. The fundus imaging system further may be configured to measure blood vessel diameters and lumen to wall thickness ratios which change in response to dysregulated vasomotor reactions in septic patients. Based on the foregoing, therefore, it should be appreciated that the present disclosure contemplates that analytics engine 20 processes and analyzes image data from a fundus imaging system to make sepsis determinations in some embodiments.

(131) Still further according to the '844 application, screening a patient for sepsis involves the use of PPG measurements, bio-impedance measurements, skin perfusion measurements, or temperature measurements at the patient's skin. During early onset of sepsis, vasodilation occurs at the endothelial level and stimuli applied at the patient's skin to produce these measurements causes less of a differential in vasodilation of septic patients than in non-septic patients. The '844 application discloses a temperature induction device that applies a range of temperatures to the patient's skin using a Peltier heater and cooler that heats or cools, respectively, the patient's skin based on a direction of current (e.g., a polarity of voltage applied) through the Peltier heater and cooler. A PPG sensor measures the patient's microvascular response to the changing temperatures. The PPG sensor includes infrared (IR) red and green light emitting diodes (LED's) in some embodiments.

(132) The '844 application also discloses an impedance sensor including electrodes attached to the patient's skin surface through which a low voltage (up to 10 Volts) sinusoidal signal is applied via the patient's skin. The impedance of the patient's skin between the electrodes is determined after heating and cooling the skin with the temperature induction device. The measured electrical impedance is then used to determine the microvascular response. In another aspect of the '844 application, a portion of a patient support apparatus, such as a hospital bed, is moved to raise a patient's extremity and to determine whether a septic patient is responding to fluid resuscitation treatment. In some embodiments, a head section or leg section of a hospital bed is raised to determine the patient's macrovascular response which is done by using vital signs measurements to determine a response to the fluid shift away from the raised extremity and toward the patient's heart.

(133) In addition to the risk factors or data elements of Tables 1-10 above, the present disclosure contemplates that any one or more of the data elements in Table 11 below can be used to calculate risk scores or to make risk determinations, including calculating the patient falls score, pressure injury score, and sepsis score discussed herein (some of the data elements being risk factors including the same risk factors as listed in Table 1):

(134) TABLE-US-00011 TABLE 11 Number Data Element 1 BED DATA 2 Connection State 3 Connectivity Protocol 4 LastKnownBedConnect 5 BedPosition (height) 6 HeadRailsPosition 7 FootRailsPosition 8 HeadAngleInDegrees 9 HeadAngleAlarmMode 10 HeadAngleAlarmAudibleMode 11 HeadAngleAlarmStatus 12 NurseCallIndicatorState 13 NurseAnswerIndicatorState 14 NaviCareAlertsIndicatorState 15 BedCleanedIndicatorState 16 BedOnlineWithServerIndicatorState 17 HeadAngleMotorLockoutState 18 KneeAngleMotorLockoutState 19 BedHeightMotorLockoutState 20 TiltAngleMotorLockoutState 21 AllMotorsLockoutState 22 BedModelName 23 SidecomSerialNumber 24 SidecomSoftwareRevision 25 PatientEnvironmentLastCommand 26 PatientHistoryLastCommand 27 ACPowerStatus 28 BatteryPowerStatus 29 PatientPositioningAlarmMode 30 PatientPositioningAlarmStatus 31 PatientMovementMagnitude 32 PatientMovementDirection 33 SafeViewMode 34 SafeViewIndicatorStatus 35 ScaleLastCommand 36 CapturePatientWeightInKg 37 CapturedPatientWeightInLbs 38 LivePatientWeightInKg 39 LivePatientWeightInLbs 40 ServiceRequiredStatus 41 SurfaceMode 42 NurseCallSwitchState 43 NaviCareAlertsSwitchState 44 CPRSwitchState 45 BedCleanedSwitchState 46 RotationTherapyStatus 47 PercussionTherapyStatus 48 VibrationTherapyStatus 49 BrakeSwitchState 50 BedServiceCode 51 FrameSerialNumber 52 PatientDetected 53 SafeViewLoLo 54 SafeViewSideRail 55 SafeViewPatientPosition 56 HeadAngleLimitEnabled 57 PatientPositionChairMode 58 SafeViewIncontinence 59 IncontinenceDetected 60 DeteriorationDetected 61 MacAddress 62 IPAddress 63 SignalStrengthInDBm 64 Load cell data 65 Log files 66 VITALS (EWS inputs) 67 Respiratory rate 68 Heart Rate 69 Pulse Rate 70 SpO2/SaO2 71 SBP 72 DBP 73 MAP 74 Temperature 75 PaO2/FiO2 76 EtCO2 77 Vitals Trend 78 Pain Score 79 Urine Output 80 LABS 81 Abnormal Labs 82 POC Blood Glucose 83 New Lab Results Received 84 Complete Blood Count (CBC) (panel) 85 White Blood Cell Count 86 Red Blood Cell Count 87 Hemoglobin (Hgb) 88 Hematocrit (Het) or Packed Cell Volume (PCV) 89 Mean Corpuscular Volume (MCV) 90 Platelet Count (Plt) 91 Mean Corpuscular Hemoglobin(MCH) 92 Mean Corpuscular Hemoglobin Concentration (MCHC) 93 Red Cell Distribution Width (RDW) 94 Platelet Distribution Width (PDW) 95 Mean Platelet Volume (MPV) 96 Reticulocyte Count 97 Basic Metabolic Panel (BMP) 98 Glucose 99 Calcium 100 Sodium 101 Potassium 102 Carbon Dioxide (aka Bicarbonate) 103 Chloride 104 Blood Urea Nitrogen (BUN) 105 Creatinine 106 When Next Labs Due 107 Normal Lab Results Ranges 108 International Normalized Ratio (INR) 109 Blood Gases 110 Partial Thromboplastin Time (PTT) 111 Activated Partial Thromboplastin Time (aPTT) 112 Prothrombin Time (PT) 113 Arterial Blood Gas (panel) 114 pH 115 PaO2 116 PaCO2 117 SaO2 118 Oxygen Content 119 Bicarbonate 120 Base Excess (BE) 121 Blood Glucose 122 Urinalysis (panel) 123 pH 124 Concentration (aka Specific Gravity) 125 Protein 126 Glucose 127 Ketones 128 Bilirubin 129 Evidence of Injection 130 Evidence of Blood 131 White Blood Cell Count 132 Red Blood Cell Count 133 Bacteria and/or yeasts 134 Casts 135 Crystals 136 Lactate 137 Platelets 138 Creatinine 139 Suspected or present Infection 140 WBC Count 141 Neutrophils/Bands 142 Bilirubin 143 INTERVENTIONS 144 Supplemental O2 145 Mechanical ventilation 146 Quarter-hourly nebulizers 147 PATIENT STATUS 148 Allergies 149 Do Not Resuscitate (DNR) 150 NPO (Nothing by the mouth) 151 Precautions (isolation, violent, elopement, psych) 152 General (language, blind/deaf, amputee, pacemaker, DVT, cardiac abnormalities, etc) 153 Dietary status 154 Capillary Refill Time 155 Color (pink/pale/gray/gray and mottled) 156 Respiratory flow rate 157 Intercostal retractions 158 Hypotension/Pressor Use 159 Ambulatory aid (none/bedrest/nurse assist/crutches/cane/walker/furniture 160 Gait (normal/bedrest/immobile/weak/unsteady/impaired) 161 Visual impairment affecting everyday function 162 Vertigo/orthostatic hypotension/weakness 163 Transfer from bed to chair (unable/needs major help/needs minor help/independent) 164 Rising from a seated position (in single movement/pushes up in one attempt/successful after multiple attempts/requires assistance) 165 Mobility (immobile/independent with wheelchair/walking aid or person assisting/independent) 166 IV/Heparin lock 167 Incontinence 168 Urgency or frequency of urination 169 Urinary catheter/ostomy 170 Elimination with assistance 171 Nocturia 172 Sedated procedure 173 Tethered patient care equipment (e.g. IV, chest tube, indwelling catheter, SCDs, etc) 174 Response to Surgery/Sedation/Anesthesia (within 24 hours/within 48 hours/more than 48 hours or none) 175 Persistent vomiting after surgery 176 Consciousness (AVPU) 177 Consciousness (GCS) 178 Mental status (oriented to own ability/forgets limitations/fully alert/agitation or anxiety/intermittently confused, confusion or disorientation) 179 Cognition (altered awareness of physical environment/impulsive/forgets limitations) 180 Behavior (playing or appropriate/sleeping/irritable/lethargic or confused or reduced pain response) 181 DEMOGRAPHICS 182 Current chronological age (observable entity) 183 Age (qualifier value) 184 Aging (finding) 185 Premature aging (finding) 186 Old-age (finding) 187 Senile debility (finding) 188 Senility (finding) 189 Extreme old age (over 100 years) (finding) 190 Senile exhaustion (finding) 191 Senile asthenia (finding) 192 Old age (qualifier value) 193 Entire life (qualifier value) 194 Old-age (finding) 195 Senile debility (finding) 196 Senility (finding) 197 Extreme old age (over 100 years) (finding) 198 Senile exhaustion (finding) 199 Senile asthenia (finding) 200 Gender (observable entity) 201 MEDICATIONS 202 Current Medications 203 Aminoglycoside (substance) 204 Analgesic (substance) 205 Medicinal product acting as analgesic agent (product) 206 Substance with opioid receptor agonist mechanism of action (substance) 207 Antiarrhythmic agent (substance) 208 Medicinal product acting as antiarrhythmic agent (product) 209 Quaternary ammonium compound with anticholinergic mechanism of action (substance) 210 Vasodilator (substance) 211 Hypotensive agent (substance) 212 Hypotensive agent (product) 213 Anti-psychotic agent (substance) 214 Medicinal product acting as antipsychotic agent (product) 215 Diuretic (substance) 216 Medicinal product acting as diuretic (product) 217 Loop diuretic (substance) 218 Loop diuretic overdose (disorder) 219 Psychoactive substance (substance) 220 Antidepressant (substance) 221 Medicinal product acting as antidepressant agent (product) 222 Anti-psychotic agent (substance) 223 Medicinal product acting as antipsychotic agent (product) 224 Benzodiazepine (substance) 225 Psychoactive substance (substance) 226 Nicotine cyclodextrin complex (substance) 227 Cannabinoid (substance) 228 Psychotropic agent (substance) 229 Nicotine polacrilex (substance) 230 Nicotine (substance) 231 Trichloroethylene (substance) 232 Central depressant (substance) 233 Nicotine resin complex (substance) 234 Medication Dosage 235 When Meds are Due 236 When Meds Last Received 237 Medication Route 238 Medication Form (liquid, pill, etc) 239 PRN (as needed medications) 240 Drug Class Type (beta blockers, barbiturates, etc) 241 DIAGNOSES/COMORBIDITIES 242 Anemia (disorder) 243 Anemia due to metabolic disorder (disorder) 244 Central nervous system calcification, deafness, tubular acidosis, anemia syndrome (disorder) 245 Fetal anemia (disorder) 246 Anemia caused by substance (disorder) 247 Anemia associated with acquired immunodeficiency syndrome (disorder) 248 Anemia due to blood loss (disorder) 249 Refractory anemia with excess blasts (disorder) 250 Sports anemia (disorder) 251 Perinatal anemia (disorder) 252 Anemia due to intrinsic red cell abnormality (disorder) 253 Normocytic anemia (disorder) 254 Deficiency anemias (disorder) 255 Neonatal anemia (disorder) 256 Microcytic anemia (disorder) 257 Anemia of renal disease (disorder) 258 Anemia of chronic disorder (disorder) 259 Dilutional anemia (disorder) 260 Chronic anemia (disorder) 261 Anemia in neoplastic disease (disorder) 262 Anemia due to disorders of nucleotide metabolism (disorder) 263 On examination - profoundly anemic (disorder) 264 On examination - clinically anemic (disorder) 265 On examination - equivocally anemic (disorder) 266 Regenerative anemia (disorder) 267 Anemia caused by physical agent (disorder) 268 Refractory anemia with excess blasts in transformation (disorder) 269 Myelodysplastic syndrome: Refractory anemia, without ringed sideroblasts, without excess blasts (disorder) 270 Anemia related to disturbed deoxyribonucleic acid synthesis (disorder) 271 Aregenerative anemia (disorder) 272 Non megaloblastic anemia due to alcoholism (disorder) 273 Macrocytic anemia (disorder) 274 Anemia due to unknown mechanism (disorder) 275 Nutritional anemia (disorder) 276 Congenital anemia (disorder) 277 Hemolytic anemia (disorder) 278 Anemia due to decreased red cell production (disorder) 279 Normocytic normochromic anemia (disorder) 280 Anemia in mother complicating pregnancy, childbirth AND/OR puerperium (disorder) 281 Anemia due to multiple mechanisms (disorder) 282 Normocytic hypochromic anemia (disorder) 283 Sideroblastic anemia (disorder) 284 Anemia due to disturbance of proliferation AND/OR differentiation of erythroid precursor cells (disorder) 285 Anemia of endocrine disorder (disorder) 286 Acquired Heinz body anemia (disorder) 287 Anemia due to disturbance of hemoglobin synthesis (disorder) 288 Relative anemia (disorder) 289 Myelophthisic anemia (disorder) 290 Cardiac arrhythmia (disorder) 291 Cardiac arrhythmia in mother complicating childbirth (disorder) 292 Arrhythmia during surgery (disorder) 293 Arrhythmia due to and following acute myocardial infarction (disorder) 294 Heart-hand syndrome type 2 (disorder) 295 Cardiac channelopathy (disorder) 296 Cardiac arrhythmia associated with genetic disorder (disorder) 297 Arrhythmia due to vegetation of infective endocarditis (disorder) 298 Bundle branch reentrant ventricular tachycardia (disorder) 299 Bradyarrhythmia (disorder) 300 Cardiac arrest (disorder) 301 Neonatal dysrhythmia (disorder) 302 Fetal dysrhythmia (disorder) 303 Atrial escape complex (disorder) 304 Ventricular escape complex (disorder) 305 Aberrantly conducted complex (disorder) 306 Aberrant premature complexes (disorder) 307 Pacemaker twiddler's syndrome (disorder) 308 Supraventricular arrhythmia (disorder) 309 Nodal rhythm disorder (disorder) 310 Atrioventricular dissociation (disorder) 311 Tic-tac rhythm (disorder) 312 Conduction disorder of the heart (disorder) 313 Ventricular arrhythmia (disorder) 314 Fibrillation (disorder) 315 Ectopic beats (disorder) 316 Premature beats (disorder) 317 Ectopic rhythm (disorder) 318 Holt-Oram syndrome (disorder) 319 Anomalous atrioventricular excitation (disorder) 320 Accelerated atrioventricular conduction (disorder) 321 Tachyarrhythmia (disorder) 322 Withdrawal arrhythmia (disorder) 323 Carotid sinus syncope (disorder) 324 Chronic obstructive lung disease (disorder) 325 Asthma-chronic obstructive pulmonary disease overlap syndrome (disorder) 326 Chronic obstructive lung disease co-occurrent with acute bronchitis (disorder) 327 Severe chronic obstructive pulmonary disease (disorder) 328 Moderate chronic obstructive pulmonary disease (disorder) 329 Mild chronic obstructive pulmonary disease (disorder) 330 Chronic obstructive pulmonary disease with acute lower respiratory infection (disorder) 331 Acute exacerbation of chronic obstructive airways disease (disorder) 332 End stage chronic obstructive airways disease (disorder) 333 Pulmonary emphysema (disorder) 334 Chronic obliterative bronchiolitis (disorder) 335 Dehydration (disorder) 336 Dehydration due to radiation (disorder) 337 Mild dehydration (disorder) 338 Moderate dehydration (disorder) 339 Dehydration following exertion (disorder) 340 Severe dehydration (disorder) 341 Hypernatremic dehydration (disorder) 342 Deprivation of water (disorder) 343 Isonatremic dehydration (disorder) 344 On examination - dehydrated (disorder) 345 Neonatal dehydration (disorder) 346 Pneumonia (disorder) 347 Pneumonia caused by Bordetella parapertussis (disorder) 348 Chronic pneumonia (disorder) 349 Idiopathic eosinophilic pneumonia (disorder) 350 Recurrent pneumonia (disorder) 351 Cavitary pneumonia (disorder) 352 Ventilator-acquired pneumonia (disorder) 353 Aspiration pneumonia (disorder) 354 Pneumonia associated with acquired immunodeficiency syndrome (disorder) 355 Bilateral pneumonia (disorder) 356 Bronchopneumonia (disorder) 357 Community acquired pneumonia (disorder) 358 Postobstructive pneumonia (disorder) 359 Postoperative pneumonia (disorder) 360 Infective pneumonia (disorder) 361 Lobar pneumonia (disorder) 362 Neonatal pneumonia (disorder) 363 Hemorrhagic pneumonia (disorder) 364 Abscess of lung with pneumonia (disorder) 365 Pneumonia and influenza (disorder) 366 Post measles pneumonia (disorder) 367 Confluent pneumonia (disorder) 368 Focal pneumonia (disorder) 369 Non-infectious pneumonia (disorder) 370 Hypostatic pneumonia (disorder) 371 Congenital pneumonia (disorder) 372 Granulomatous pneumonia (disorder) 373 Organized pneumonia (disorder) 374 Interstitial pneumonia (disorder) 375 Unresolved pneumonia (disorder) 376 Catarrhal pneumonia (disorder) 377 Gangrenous pneumonia (disorder) 378 Sepsis (disorder) 379 Sepsis due to incomplete miscarriage (disorder) 380 Sepsis due to ectopic pregnancy (disorder) 381 Sepsis without acute organ dysfunction (disorder) 382 Line sepsis associated with dialysis catheter (disorder) 383 Sepsis caused by virus (disorder) 384 Sepsis due to urinary tract infection (disorder) 385 Perinatal sepsis (disorder) 386 Sepsis due to oral infection (disorder) 387 Sepsis with cutaneous manifestations (disorder) 388 Sepsis caused by fungus (disorder) 389 Sepsis associated with acquired immunodeficiency syndrome (disorder) 390 Sepsis in asplenic subject (disorder) 391 Postoperative sepsis (disorder) 392 Induced termination of pregnancy complicated by sepsis (disorder) 393 Sepsis caused by herpes simplex (disorder) 394 Neutropenic sepsis (disorder) 395 Transient respiratory distress with sepsis (disorder) 396 Umbilical sepsis (disorder) 397 Sepsis of the newborn (disorder) 398 Miscarriage with sepsis (disorder) 399 Sepsis following infusion, injection, transfusion AND/OR vaccination (disorder) 400 Sepsis following molar AND/OR ectopic pregnancy (disorder) 401 Pyemia (disorder) 402 Tracheostomy sepsis (disorder) 403 Failed attempted abortion with sepsis (disorder) 404 Acute tubulointerstitial nephritis associated with systemic infection (disorder) 405 Bacterial sepsis (disorder) 406 Brazilian purpuric fever (disorder) 407 Gas gangrene septicemia (disorder) 408 Puerperal sepsis (disorder) 409 Intrauterine sepsis of fetus (disorder) 410 Diabetes mellitus (disorder) 411 Atypical diabetes mellitus (disorder) 412 Diabetes mellitus due to pancreatic injury (disorder) 413 Erectile dysfunction co-occurrent and due to diabetes mellitus (disorder) 414 Acute complication co-occurrent and due to diabetes mellitus (disorder) 415 Metabolic acidosis co-occurrent and due to diabetes mellitus (disorder) 416 Lactic acidosis co-occurrent and due to diabetes mellitus (disorder) 417 Alaninuria, microcephaly, dwarfism, enamel hypoplasia, diabetes mellitus syndrome (disorder) 418 Diabetic mastopathy (disorder) 419 Pancreatic hypoplasia, diabetes mellitus, congenital heart disease syndrome (disorder) 420 Gingival disease co-occurrent with diabetes mellitus (disorder) 421 Diabetes mellitus in remission (disorder) 422 Diabetes mellitus due to genetic defect in insulin action (disorder) 423 Diabetes mellitus due to genetic defect in beta cell function (disorder) 424 Disorder of nervous system co-occurrent and due to diabetes mellitus (disorder) 425 Peripheral vascular disorder co-occurrent and due to diabetes mellitus (disorder) 426 Disorder of soft tissue co-occurrent and due to diabetes mellitus (disorder) 427 Diabetes mellitus during pregnancy, childbirth and the puerperium (disorder) 428 Disorder of kidney co-occurrent and due to diabetes mellitus (disorder) 429 Houssay's syndrome (disorder) 430 Diabetes mellitus without complication (disorder) 431 Diabetes mellitus type 1 (disorder) 432 Diabetes mellitus type 2 (disorder) 433 Disorder of eye co-occurrent and due to diabetes mellitus (disorder) 434 Secondary diabetes mellitus (disorder) 435 Disorder of thyroid gland (disorder) 436 Nodular thyroid disease (disorder) 437 Thyrocerebrorenal syndrome (disorder) 438 Hypoplasia of thyroid (disorder) 439 Thyroid infection (disorder) 440 Perinatal thyroid disorder (disorder) 441 Thyroid dysfunction (disorder) 442 Injury of thyroid gland (disorder) 443 Iodine deficiency syndrome (disorder) 444 Thyroid hormone binding abnormality (disorder) 445 Sick-euthyroid syndrome (disorder) 446 Thyroid atrophy (disorder) 447 Disorder of thyrocalcitonin secretion (disorder) 448 Neoplasm of thyroid gland (disorder) 449 Complex thyroid endocrine disorder (disorder) 450 Abscess of thyroid (disorder) 451 Thyroiditis (disorder) 452 Cyst of thyroid (disorder) 453 Transient decreased production of thyroid hormone (disorder) 454 Multiple endocrine neoplasia, type 3 (disorder) 455 Thyroid disease in mother complicating pregnancy, childbirth AND/OR puerperium (disorder) 456 Hypothyroidism (disorder) 457 Inherited disorder of thyroid metabolism (disorder) 458 Hyperthyroidism (disorder) 459 Congenital anomaly of the thyroid gland (disorder) 460 Ascher's syndrome (disorder) 461 Hurthle cell metaplasia of thyroid gland (disorder) 462 Infarction of thyroid (disorder) 463 Goiter (disorder) 464 Hemorrhage of thyroid (disorder) 465 Hypersecretion of calcitonin (disorder) 466 Hypoglycemia (disorder) 467 Post gastrointestinal tract surgery hypoglycemia (disorder) 468 Neonatal hypoglycemia (disorder) 469 Diabetic hyperosmolar non-ketotic state (disorder) 470 Hyperosmolar hyperglycemic coma due to diabetes mellitus without ketoacidosis (disorder) 471 Hyperosmolar non-ketotic state in type 2 diabetes mellitus (disorder) 472 Orthostatic hypotension (disorder) 473 Postural hypotension following exercise (disorder) 474 Orthostatic hypotension co-occurrent and due to Parkinson's disease (disorder) 475 Postural orthostatic tachycardia syndrome (disorder) 476 Sympathotonic orthostatic hypotension (disorder) 477 Chronic orthostatic hypotension (disorder) 478 Hypoadrenergic postural hypotension (disorder) 479 Hyperadrenergic postural hypotension (disorder) 480 Congestive heart failure due to valvular disease (disorder) 481 Delirium (disorder) 482 Delirium following surgical procedure (disorder) 483 Delirium co-occurrent with dementia (disorder) 484 Delirium due to multiple etiological factors (disorder) 485 Delirium caused by substance or medication (disorder) 486 Delirium in remission (disorder) 487 Chronic confusional state (disorder) 488 Psychosis associated with intensive care (disorder) 489 Delirium of mixed origin (disorder) 490 Toxic confusional state (disorder) 491 Subacute delirium (disorder) 492 Acute confusional state, of cerebrovascular origin (disorder) 493 Acute confusional state, of metabolic origin (disorder) 494 Acute confusional state, of endocrine origin (disorder) 495 Acute confusional state, of infective origin (disorder) 496 Acute confusional state, post-traumatic (disorder) 497 Drug-induced delirium (disorder) 498 Acute non-psychotic brain syndrome (disorder) 499 Postseizure delirium (disorder) 500 Multi-infarct dementia with delirium (disorder) 501 Dementia (disorder) 502 Primary degenerative dementia (disorder) 503 Dementia with behavioral disturbance (disorder) 504 Protein kinase cAMP-dependent type I regulatory subunit beta-related neurodegenerative dementia with intermediate filaments (disorder) 505 Subcortical dementia (disorder) 506 Dementia following injury caused by exposure to ionizing radiation (disorder) 507 Dementia caused by heavy metal exposure (disorder) 508 Delirium co-occurrent with dementia (disorder) 509 Rapidly progressive dementia (disorder) 510 Dementia caused by toxin (disorder) 511 Parkinsonism co-occurrent with dementia of Guadeloupe (disorder) 512 Dementia co-occurrent with human immunodeficiency virus infection (disorder) 513 Dementia in remission (disorder) 514 Dementia of frontal lobe type (disorder) 515 Senile and presenile organic psychotic conditions (disorder) 516 Patchy dementia (disorder) 517 Semantic dementia (disorder) 518 Dementia associated with another disease (disorder) 519 Drug-induced dementia (disorder) 520 Parkinson-dementia complex of Guam (disorder) 521 General paresis - neurosyphilis (disorder) 522 Alzheimer's disease (disorder) 523 Senile dementia (disorder) 524 Presenile dementia (disorder) 525 Dialysis dementia (disorder) 526 Cerebrovascular accident (disorder) 527 Cerebellar stroke (disorder) 528 Cerebrovascular accident due to stenosis of left carotid artery (disorder) 529 Cerebrovascular accident due to stenosis of right carotid artery (disorder) 530 Cerebrovascular accident due to occlusion of right cerebellar artery (disorder) 531 Cerebrovascular accident due to occlusion of left cerebellar artery (disorder) 532 Cerebrovascular accident due to occlusion of left carotid artery (disorder) 533 Cerebrovascular accident due to occlusion of right pontine artery (disorder) 534 Cerebrovascular accident due to occlusion of left pontine artery (disorder) 535 Cerebrovascular accident due to occlusion of right carotid artery (disorder) 536 Cerebrovascular accident due to occlusion of left vertebral artery (disorder) 537 Cerebrovascular accident due to occlusion of right vertebral artery (disorder) 538 Cerebrovascular accident due to stenosis of left vertebral artery (disorder) 539 Cerebrovascular accident due to stenosis of right vertebral artery (disorder) 540 Occlusion of cerebral artery with stroke (disorder) 541 Stroke co-occurrent with migraine (disorder) 542 Silent cerebral infarct (disorder) 543 Cerebrovascular accident during surgery (disorder) 544 Ischemic stroke (disorder) 545 Infarction of basal ganglia (disorder) 546 Neonatal stroke (disorder) 547 Embolic stroke (disorder) 548 Thrombotic stroke (disorder) 549 Extension of cerebrovascular accident (disorder) 550 Stroke in the puerperium (disorder) 551 Ruptured cerebral aneurysm (disorder) 552 Stroke of uncertain pathology (disorder) 553 Cerebrovascular accident due to occlusion of cerebral artery (disorder) 554 Right sided cerebral hemisphere cerebrovascular accident (disorder) 555 Left sided cerebral hemisphere cerebrovascular accident (disorder) 556 Brainstem stroke syndrome (disorder) 557 Paralytic stroke (disorder) 558 Nonparalytic stroke (disorder) 559 Intracranial sinus thrombosis, embolism AND/OR inflammation (disorder) 560 Progressing stroke (disorder) 561 Juvenile myopathy, encephalopathy, lactic acidosis AND stroke (disorder) 562 Completed stroke (disorder) 563 Anterior choroidal artery syndrome (disorder) 564 Arthritis (disorder) 565 Arthritis of right sternoclavicular joint (disorder) 566 Arthritis of left sternoclavicular joint (disorder) 567 Primary chronic gout without tophus of shoulder (disorder) 568 Gout of shoulder caused by drug (disorder) 569 Transient arthritis (disorder) 570 Arthritis of wrist (disorder) 571 Interstitial granulomatous dermatitis with arthritis (disorder) 572 Immune dysregulation, inflammatory bowel disease, arthritis, recurrent infection syndrome (disorder) 573 Monoarthritis (disorder) 574 Inflammation of joint of hand (disorder) 575 Inflammation of joint of shoulder region (disorder) 576 Arthritis of elbow (disorder) 577 Arthritis of acromioclavicular joint (disorder) 578 Inflammatory polyarthropathy (disorder) 579 Undifferentiated inflammatory arthritis (disorder) 580 Synovitis (disorder) 581 Seronegative arthritis (disorder) 582 Infective arthritis (disorder) 583 Suppurative arthritis (disorder) 584 Arthritis of spine (disorder) 585 Cricoarytenoid joint arthritis (disorder) 586 Lower limb joint arthritis (disorder) 587 Small and large joint arthritis (disorder) 588 Large joint arthritis (disorder) 589 Small joint arthritis (disorder) 590 Asymmetrical arthritis (disorder) 591 Symmetrical arthritis (disorder) 592 Cholesterol-related arthritis and periarthritis (disorder) 593 Oxalate-related arthritis and periarthritis (disorder) 594 Idiopathic pyrophosphate arthritis (disorder) 595 Chronic infantile neurological, cutaneous and articular syndrome (disorder) 596 Arthritis following intestinal bypass (disorder) 597 Post-immunization arthritis (disorder) 598 Palindromic rheumatism of the pelvic region and thigh (disorder) 599 Palindromic rheumatism of the shoulder region (disorder) 600 Generalized arthritis (disorder) 601 Erosive osteoarthrosis (disorder) 602 Arthropathy in Crohn's disease (disorder) 603 Systemic lupus erythematosus arthritis (disorder) 604 Arthritis of temporomandibular joint (disorder) 605 Climacteric arthritis (disorder) 606 Osteochondritis (disorder) 607 Rheumatoid arthritis (disorder) 608 Subacute arthritis (disorder) 609 Chronic arthritis (disorder) 610 Acute arthritis (disorder) 611 Arthritis associated with another disorder (disorder) 612 Deformity of foot (finding) 613 Acquired overriding toes of left foot (disorder) 614 Acquired overriding toes of right foot (disorder) 615 Deformity of foot due to rheumatoid arthritis (finding) 616 Putter foot (finding) 617 Pronation deformity of the foot (finding) 618 Supination deformity of the foot (finding) 619 Pronated forefoot (finding) 620 Supinated forefoot (finding) 621 Adductus deformity of foot (finding) 622 Plantarflexion deformity of foot (finding) 623 Abduction deformity of the foot (finding) 624 Acquired curly toe (disorder) 625 Dorsiflexion deformity of foot (finding) 626 Acquired valgus heel (disorder) 627 Overriding fifth toe (disorder) 628 Overriding toe (disorder) 629 Muscle weakness (finding) 630 Muscle weakness of limb (finding) 631 Spastic paresis (finding) 632 Hand muscle weakness (finding) 633 Pyramidal type muscle weakness (finding) 634 Distal muscle weakness (finding) 635 Proximal muscle weakness (finding) 636 Truncal muscle weakness (finding) 637 Weakness of sternomastoid (finding) 638 Weakness of jaw muscles (finding) 639 On examination - muscle power reduced (finding) 640 On examination - paresis (weakness) (finding) 641 Weakness present (finding) 642 Pseudoparalysis (finding) 643 Palatal paresis (finding) 644 Laryngeal paresis (finding) 645 Pharyngeal paresis (finding) 646 Bilateral paresis (finding) 647 Subjective muscle weakness (finding) 648 Paresis of lower extremity (finding) 649 Weakness of face muscles (finding) 650 Diaphragmatic paresis (finding) 651 Neurological muscle weakness (finding) 652 Spinal paraparesis (finding) 653 Spinal hemiparesis (finding) 654 Inherited spastic paresis (disorder) 655 Cerebellar degeneration (disorder) 656 Acute cerebellar syndrome (disorder) 657 Secondary cerebellar degeneration (disorder) 658 Cerebellar deficiency syndrome (disorder) 659 Posthemiplegic ataxia (disorder) 660 Primary progressive cerebellar degeneration (disorder) 661 Juvenile cerebellar degeneration AND myoclonus (disorder) 662 Olivopontocerebellar degeneration (disorder) 663 Paramyoclonus multiplex (disorder) 664 Bailey-Cushing syndrome (disorder) 665 Jervis' syndrome (disorder) 666 Roussy-Lévy syndrome (disorder) 667 Corticostriatal-spinal degeneration (disorder) 668 Hereditary cerebellar degeneration (disorder) 669 Primary cerebellar degeneration (disorder) 670 Sporadic cerebellar degeneration (disorder) 671 Friedreich's ataxia (disorder) 672 Athetosis with spastic paraplegia (disorder) 673 Cervical myelopathy (disorder) 674 Myelopathy co-occurrent and due to spinal stenosis of cervical region (disorder) 675 Parkinsonism (disorder) 676 X-linked parkinsonism with spasticity syndrome (disorder) 677 Hemiparkinsonism hemiatrophy syndrome (disorder) 678 Autosomal dominant striatal neurodegeneration (disorder) 679 Functional parkinsonism (disorder) 680 Parkinsonism due to mass lesion of brain (disorder) 681 Infection causing parkinsonism (disorder) 682 Kufor Rakeb syndrome (disorder) 683 Atypical Parkinsonism (disorder) 684 Infantile dystonia parkinsonism (disorder) 685 Adult-onset dystonia parkinsonism (disorder) 686 Psychosis co-occurrent and due to Parkinson's disease (disorder) 687 Parkinsonism co-occurrent with dementia of Guadeloupe (disorder) 688 Rapid onset dystonia parkinsonism (disorder) 689 Perry syndrome (disorder) 690 X-linked dystonia parkinsonism (disorder) 691 On - off phenomenon (disorder) 692 Symptomatic parkinsonism (disorder) 693 Secondary parkinsonism (disorder) 694 Parkinsonian syndrome associated with idiopathic orthostatic hypotension (disorder) 695 Parkinson-dementia complex of Guam (disorder) 696 Parkinson's disease (disorder) 697 Striatonigral degeneration (disorder) 698 Peripheral nerve disease (disorder) 699 Paraneoplastic peripheral neuropathy (disorder) 700 Primary CD59 deficiency (disorder) 701 Peripheral neuropathy due to and following chemotherapy (disorder) 702 Morvan syndrome (disorder) 703 Acquired hypoganglionosis of large intestine (disorder) 704 Deafness, small bowel diverticulosis, neuropathy syndrome (disorder) 705 Peripheral neuropathy due to hypervitaminosis B6 (disorder) 706 Length-dependent peripheral neuropathy (disorder) 707 Autosomal dominant optic atrophy and peripheral neuropathy syndrome (disorder) 708 Peripheral neuropathy due to metabolic disorder (disorder) 709 Small fiber neuropathy (disorder) 710 Peripheral neuropathy due to inflammation (disorder) 711 Peripheral neuropathy caused by toxin (disorder) 712 Neuropathy of lower limb (disorder) 713 Neuropathy of upper limb (disorder) 714 Ependymal cyst of spinal nerve (disorder) 715 Peripheral nerve disorder associated with repair of hernia (disorder) 716 Facial nerve disorder (disorder) 717 Abducens nerve disorder (disorder) 718 Pudendal nerve neuropathy (disorder) 719 Neuromyotonia (disorder) 720 Thoracoabdominal neuropathy (disorder) 721 Long thoracic nerve lesion (disorder) 722 Disorder of peripheral nerve graft (disorder) 723 Peripheral nerve decompression injury (disorder) 724 Intercostal neuropathy (disorder) 725 Compression neuropathy of trunk (disorder) 726 Ischemic neuropathy (disorder) 727 Leprosy neuropathy (disorder) 728 Peripheral axonal neuropathy (disorder) 729 Phrenic nerve disorder (disorder) 730 Peripheral neuritis (disorder) 731 Mononeuropathy (disorder) 732 Neoplasm of peripheral nerve (disorder) 733 Celiac plexus syndrome (disorder) 734 Perineurial cyst (disorder) 735 Disorder of glossopharyngeal nerve (disorder) 736 Disorder of acoustic nerve (disorder) 737 Brachial plexus neuralgia (disorder) 738 Disorder of vagus nerve (disorder) 739 Peripheral nerve injury (disorder) 740 Nerve root disorder (disorder) 741 Trigeminal nerve disorder (disorder) 742 Third cranial nerve disease (disorder) 743 Polyneuropathy (disorder) 744 Disorder of hypoglossal nerve (disorder) 745 Congenital anomaly of peripheral nerve (disorder) 746 Peripheral demyelinating neuropathy (disorder) 747 Familial visceral neuropathy (disorder) 748 Fourth nerve palsy (disorder) 749 Cerebrovascular accident (disorder) 750 Cerebellar stroke (disorder) 751 Cerebrovascular accident due to stenosis of left carotid artery (disorder) 752 Cerebrovascular accident due to stenosis of right carotid artery (disorder) 753 Cerebrovascular accident due to occlusion of right cerebellar artery (disorder) 754 Cerebrovascular accident due to occlusion of left cerebellar artery (disorder) 755 Cerebrovascular accident due to occlusion of left carotid artery (disorder) 756 Cerebrovascular accident due to occlusion of right pontine artery (disorder) 757 Cerebrovascular accident due to occlusion of left pontine artery (disorder) 758 Cerebrovascular accident due to occlusion of right carotid artery (disorder) 759 Cerebrovascular accident due to occlusion of left vertebral artery (disorder) 760 Cerebrovascular accident due to occlusion of right vertebral artery (disorder) 761 Cerebrovascular accident due to stenosis of left vertebral artery (disorder) 762 Cerebrovascular accident due to stenosis of right vertebral artery (disorder) 763 Occlusion of cerebral artery with stroke (disorder) 764 Stroke co-occurrent with migraine (disorder) 765 Silent cerebral infarct (disorder) 766 Cerebrovascular accident during surgery (disorder) 767 Ischemic stroke (disorder) 768 Infarction of basal ganglia (disorder) 769 Neonatal stroke (disorder) 770 Embolic stroke (disorder) 771 Thrombotic stroke (disorder) 772 Extension of cerebrovascular accident (disorder) 773 Stroke in the puerperium (disorder) 774 Ruptured cerebral aneurysm (disorder) 775 Stroke of uncertain pathology (disorder) 776 Cerebrovascular accident due to occlusion of cerebral artery (disorder) 777 Right sided cerebral hemisphere cerebrovascular accident (disorder) 778 Left sided cerebral hemisphere cerebrovascular accident (disorder) 779 Brainstem stroke syndrome (disorder) 780 Paralytic stroke (disorder) 781 Nonparalytic stroke (disorder) 782 Intracranial sinus thrombosis, embolism AND/OR inflammation (disorder) 783 Progressing stroke (disorder) 784 Juvenile myopathy, encephalopathy, lactic acidosis AND stroke (disorder) 785 Completed stroke (disorder) 786 Anterior choroidal artery syndrome (disorder) 787 Basilar artery syndrome (disorder) 788 Peripheral neuropathy co-occurrent and due to diabetes mellitus (disorder) 789 Peripheral neuropathy co-occurrent and due to type 1 diabetes mellitus (disorder) 790 Peripheral neuropathy co-occurrent and due to type 2 diabetes mellitus (disorder) 791 Ophthalmoplegia co-occurrent and due to diabetes mellitus (disorder) 792 Mononeuropathy co-occurrent and due to diabetes mellitus (disorder) 793 Asymmetric proximal motor neuropathy co-occurrent and due to diabetes mellitus (disorder) 794 Polyneuropathy co-occurrent and due to diabetes mellitus (disorder) 795 Radiculoplexus neuropathy co-occurrent and due to diabetes mellitus (disorder) 796 Symmetric proximal motor neuropathy co-occurrent and due to diabetes mellitus (disorder) 797 Pseudotabes co-occurrent and due to diabetes mellitus (disorder) 798 Cobalamin deficiency (disorder) 799 Fetal or neonatal vitamin B12 deficiency due to maternal vitamin B12 deficiency (disorder) 800 Vitamin B12 deficiency (non anemic) (disorder) 801 Acute mastoiditis with labyrinthitis (disorder) 802 Benign paroxysmal positional vertigo (disorder) 803 Benign paroxysmal positional vertigo or nystagmus (disorder) 804 Benign paroxysmal vertigo of childhood (disorder) 805 Hearing loss (disorder) 806 Mild to moderate hearing loss (disorder) 807 Severe hearing loss (disorder) 808 Aphonia, deafness, retinal dystrophy, bifid halluces, intellectual disability syndrome (disorder) 809 Acquired hearing loss (disorder) 810 Oro-facial digital syndrome type 11 (disorder) 811 Deafness craniofacial syndrome (disorder) 812 Microcephaly with deafness and intellectual disability syndrome (disorder) 813 Hearing loss of left ear (disorder) 814 Hearing loss of right ear (disorder) 815 Combined visual and hearing impairment (disorder) 816 Asymmetrical hearing loss (disorder) 817 Partial deafness (disorder) 818 On examination - deaf (disorder) 819 Deafness symptom (disorder) 820 Chronic deafness (disorder) 821 On examination - significantly deaf (disorder) 822 Bilateral deafness (disorder) 823 Birth trauma deafness (disorder) 824 Congenital anomaly of ear with impairment of hearing (disorder) 825 Neonatal hearing loss (disorder) 826 Bilateral hearing loss (disorder) 827 Traumatic deafness (disorder) 828 Sudden hearing loss (disorder) 829 Noise-induced hearing loss (disorder) 830 Deaf mutism (disorder) 831 Sensorineural hearing loss (disorder) 832 Tone deafness (disorder) 833 Upper frequency deafness (disorder) 834 Conductive hearing loss (disorder) 835 Paradoxic hearing loss (disorder) 836 Toxic deafness (disorder) 837 Psychogenic deafness (disorder) 838 Robinson nail dystrophy-deafness syndrome (disorder) 839 Complete deafness (disorder) 840 Ménière's disease (disorder) 841 Meniere's disease of right inner ear (disorder) 842 Meniere's disease of left inner ear (disorder) 843 Familial Ménière disease (disorder) 844 Vestibular Ménière syndrome (disorder) 845 Cochlear Ménière syndrome (disorder) 846 Inactive Ménière's disease (disorder) 847 Active Ménière's disease (disorder) 848 Cataract (disorder) 849 Infantile and/or juvenile cataract (disorder) 850 Microcornea, rod-cone dystrophy, cataract, posterior staphyloma syndrome (disorder) 851 Cataract due to pseudohypoparathyroidism (disorder) 852 Cataract due to idiopathic hypoparathyroidism (disorder) 853 Cochleosaccular degeneration and cataract syndrome (disorder) 854 Hyperferritinemia cataract syndrome (disorder) 855 Immature cataract (disorder) 856 Presenile cataract (disorder) 857 Nonsenile cataract (disorder) 858 Suture tip cataract (disorder) 859 Mixed type cataract (disorder) 860 Hypermature cataract (disorder) 861 Rubella cataract (disorder) 862 Cataract in systemic disorders (disorder) 863 Capsular cataract (disorder) 864 Drug-induced cataract (disorder) 865 Lamellar zonular cataract (disorder) 866 Cortical cataract (disorder) 867 Infantile, juvenile and presenile cataracts (disorder) 868 On examination - lens - early opacity (disorder) 869 Partial cataract (disorder) 870 Adherent cataract (disorder) 871 Stationary cataract (disorder) 872 Axial cataract (disorder) 873 Subcapsular cataract (disorder) 874 Bilateral cataracts (disorder) 875 Congenital cataract (disorder) 876 Cataract with neovascularization (disorder) 877 Cataract associated with radiation (disorder) 878 Postoperative cataract syndrome (disorder) 879 Nuclear cataract (disorder) 880 Incipient cataract (disorder) 881 Localized traumatic opacity (disorder) 882 Punctate cataract (disorder) 883 Age-related cataract (disorder) 884 Toxic cataract (disorder) 885 Traumatic cataract (disorder) 886 Cataract in inflammatory disorder (disorder) 887 Coronary cataract (disorder) 888 Calcified cataract (disorder) 889 Atopic cataract (disorder) 890 Mature cataract (disorder) 891 Glaucoma (disorder) 892 Glaucoma and sleep apnea syndrome (disorder) 893 Angle-closure glaucoma (disorder) 894 Acute-on-chronic glaucoma (disorder) 895 Glaucoma with intraocular hemorrhage (disorder) 896 Iatrogenic glaucoma (disorder) 897 Congenital glaucoma (disorder) 898 Borderline glaucoma (disorder) 899 Secondary glaucoma (disorder) 900 Glaucoma due to combination of mechanisms (disorder) 901 Open-angle glaucoma (disorder) 902 Glaucoma of childhood (disorder) 903 Glaucoma associated with ocular disorder (disorder) 904 Glaucoma associated with systemic syndromes (disorder) 905 Low tension glaucoma (disorder) 906 Anatomical narrow angle glaucoma (disorder) 907 Hypersecretion glaucoma (disorder) 908 Glaucoma associated with tumors AND/OR cysts (disorder) 909 Absolute glaucoma (disorder) 910 Aphakic glaucoma (disorder) 911 Glaucomatous atrophy of optic disc (disorder) 912 Age-related macular degeneration (disorder) 913 Nonexudative age-related macular degeneration (disorder) 914 Exudative age-related macular degeneration (disorder) 915 Drusen plus pigment change stage macular degeneration (disorder) 916 Fibrovascular macular scar (disorder) 917 Drusen stage macular degeneration (disorder) 918 Muscle weakness (finding) 919 Muscle weakness of limb (finding) 920 Spastic paresis (finding) 921 Hand muscle weakness (finding) 922 Pyramidal type muscle weakness (finding) 923 Distal muscle weakness (finding) 924 Proximal muscle weakness (finding) 925 Truncal muscle weakness (finding) 926 Weakness of sternomastoid (finding) 927 Weakness of jaw muscles (finding) 928 On examination - muscle power reduced (finding) 929 On examination - paresis (weakness) (finding) 930 Weakness present (finding) 931 Pseudoparalysis (finding) 932 Palatal paresis (finding) 933 Laryngeal paresis (finding) 934 Pharyngeal paresis (finding) 935 Bilateral paresis (finding) 936 Subjective muscle weakness (finding) 937 Paresis of lower extremity (finding) 938 Weakness of face muscles (finding) 939 Diaphragmatic paresis (finding) 940 Neurological muscle weakness (finding) 941 Spinal paraparesis (finding) 942 Spinal hemiparesis (finding) 943 Inherited spastic paresis (disorder) 944 Abnormal gait due to impairment of balance (finding) 945 Impairment of balance (finding) 946 Difficulty balancing (finding) 947 Does not balance (finding) 948 Unable to balance (finding) 949 General unsteadiness (finding) 950 Equilibration disorder, vestibular nerve (disorder) 951 Unsteady when turning (finding) 952 Unsteady when standing (finding) 953 Poor balance (finding) 954 Keeps losing balance (finding) 955 Feels as though will fall (finding) 956 Romberg test positive and direction of fall affected by head turn (finding) 957 Romberg test evokes stiff fall backward (finding) 958 Loss of equilibrium (finding) 959 Visual impairment (disorder) 960 Bilateral visual impairment (disorder) 961 Visual impairment co-occurrent with human immunodeficiency virus infection (disorder) 962 Drug related visual impairment (disorder) 963 Combined visual and hearing impairment (disorder) 964 Multiple disability visual impairment (disorder) 965 Mild visual impairment (disorder) 966 Moderate visual impairment (disorder) 967 Severe visual impairment (disorder) 968 Orthostatic hypotension (disorder) 969 Postural hypotension following exercise (disorder) 970 Orthostatic hypotension co-occurrent and due to Parkinson's disease (disorder) 971 Postural orthostatic tachycardia syndrome (disorder) 972 Sympathotonic orthostatic hypotension (disorder) 973 Chronic orthostatic hypotension (disorder) 974 Hypoadrenergic postural hypotension (disorder) 975 Hyperadrenergic postural hypotension (disorder) 976 Arthritis (disorder) 977 Arthritis of right sternoclavicular joint (disorder) 978 Arthritis of left sternoclavicular joint (disorder) 979 Primary chronic gout without tophus of shoulder (disorder) 980 Gout of shoulder caused by drug (disorder) 981 Transient arthritis (disorder) 982 Arthritis of wrist (disorder) 983 Interstitial granulomatous dermatitis with arthritis (disorder) 984 Immune dysregulation, inflammatory bowel disease, arthritis, recurrent infection syndrome (disorder) 985 Monoarthritis (disorder) 986 Inflammation of joint of hand (disorder) 987 Inflammation of joint of shoulder region (disorder) 988 Arthritis of elbow (disorder) 989 Arthritis of acromioclavicular joint (disorder) 990 Inflammatory polyarthropathy (disorder) 991 Undifferentiated inflammatory arthritis (disorder) 992 Synovitis (disorder) 993 Seronegative arthritis (disorder) 994 Infective arthritis (disorder) 995 Suppurative arthritis (disorder) 996 Arthritis of spine (disorder) 997 Cricoarytenoid joint arthritis (disorder) 998 Lower limb joint arthritis (disorder) 999 Small and large joint arthritis (disorder) 1000 Large joint arthritis (disorder) 1001 Small joint arthritis (disorder) 1002 Asymmetrical arthritis (disorder) 1003 Symmetrical arthritis (disorder) 1004 Cholesterol-related arthritis and periarthritis (disorder) 1005 Oxalate-related arthritis and periarthritis (disorder) 1006 Idiopathic pyrophosphate arthritis (disorder) 1007 Chronic infantile neurological, cutaneous and articular syndrome (disorder) 1008 Arthritis following intestinal bypass (disorder) 1009 Post-immunization arthritis (disorder) 1010 Palindromic rheumatism of the pelvic region and thigh (disorder) 1011 Palindromic rheumatism of the shoulder region (disorder) 1012 Generalized arthritis (disorder) 1013 Erosive osteoarthrosis (disorder) 1014 Arthropathy in Crohn's disease (disorder) 1015 Systemic lupus erythematosus arthritis (disorder) 1016 Arthritis of temporomandibular joint (disorder) 1017 Climacteric arthritis (disorder) 1018 Osteochondritis (disorder) 1019 Rheumatoid arthritis (disorder) 1020 Subacute arthritis (disorder) 1021 Chronic arthritis (disorder) 1022 Acute arthritis (disorder) 1023 Arthritis associated with another disorder (disorder) 1024 Cerebrovascular accident (disorder) 1025 Cerebellar stroke (disorder) 1026 Cerebrovascular accident due to stenosis of left carotid artery (disorder) 1027 Cerebrovascular accident due to stenosis of right carotid artery (disorder) 1028 Cerebrovascular accident due to occlusion of right cerebellar artery (disorder) 1029 Cerebrovascular accident due to occlusion of left cerebellar artery (disorder) 1030 Cerebrovascular accident due to occlusion of left carotid artery (disorder) 1031 Cerebrovascular accident due to occlusion of right pontine artery (disorder) 1032 Cerebrovascular accident due to occlusion of left pontine artery (disorder) 1033 Cerebrovascular accident due to occlusion of right carotid artery (disorder) 1034 Cerebrovascular accident due to occlusion of left vertebral artery (disorder) 1035 Cerebrovascular accident due to occlusion of right vertebral artery (disorder) 1036 Cerebrovascular accident due to stenosis of left vertebral artery (disorder) 1037 Cerebrovascular accident due to stenosis of right vertebral artery (disorder) 1038 Occlusion of cerebral artery with stroke (disorder) 1039 Stroke co-occurrent with migraine (disorder) 1040 Silent cerebral infarct (disorder) 1041 Cerebrovascular accident during surgery (disorder) 1042 Ischemic stroke (disorder) 1043 Infarction of basal ganglia (disorder) 1044 Neonatal stroke (disorder) 1045 Embolic stroke (disorder) 1046 Thrombotic stroke (disorder) 1047 Extension of cerebrovascular accident (disorder) 1048 Stroke in the puerperium (disorder) 1049 Ruptured cerebral aneurysm (disorder) 1050 Stroke of uncertain pathology (disorder) 1051 Cerebrovascular accident due to occlusion of cerebral artery (disorder) 1052 Right sided cerebral hemisphere cerebrovascular accident (disorder) 1053 Left sided cerebral hemisphere cerebrovascular accident (disorder) 1054 Brainstem stroke syndrome (disorder) 1055 Paralytic stroke (disorder) 1056 Nonparalytic stroke (disorder) 1057 Intracranial sinus thrombosis, embolism AND/OR inflammation (disorder) 1058 Progressing stroke (disorder) 1059 Juvenile myopathy, encephalopathy, lactic acidosis AND stroke (disorder) 1060 Completed stroke (disorder) 1061 Anterior choroidal artery syndrome (disorder) 1062 Urinary incontinence (finding) 1063 Urinary incontinence due to benign prostatic hypertrophy (finding) 1064 Urinary incontinence co-occurrent and due to prolapse of female genital organ (disorder) 1065 Intermittent urinary incontinence (finding) 1066 Urinary incontinence due to urethral sphincter incompetence (finding) 1067 Total urinary incontinence (finding) 1068 Double incontinence (finding) 1069 Urinary incontinence of non-organic origin (finding) 1070 Parkinson's disease (disorder) 1071 Sporadic Parkinson disease (disorder) 1072 Orthostatic hypotension co-occurrent and due to Parkinson's disease (disorder) 1073 Autosomal dominant late onset Parkinson disease (disorder) 1074 Young onset Parkinson disease (disorder) 1075 Juvenile Parkinson's disease (disorder) 1076 Dementia (disorder) 1077 Primary degenerative dementia (disorder) 1078 Dementia with behavioral disturbance (disorder) 1079 Protein kinase cAMP-dependent type I regulatory subunit beta-related neurodegenerative dementia with intermediate filaments (disorder) 1080 Subcortical dementia (disorder) 1081 Dementia following injury caused by exposure to ionizing radiation (disorder) 1082 Dementia caused by heavy metal exposure (disorder) 1083 Delirium co-occurrent with dementia (disorder) 1084 Rapidly progressive dementia (disorder) 1085 Dementia caused by toxin (disorder) 1086 Parkinsonism co-occurrent with dementia of Guadeloupe (disorder) 1087 Dementia co-occurrent with human immunodeficiency virus infection (disorder) 1088 Dementia in remission (disorder) 1089 Dementia of frontal lobe type (disorder) 1090 Senile and presenile organic psychotic conditions (disorder) 1091 Patchy dementia (disorder) 1092 Semantic dementia (disorder) 1093 Dementia associated with another disease (disorder) 1094 Drug-induced dementia (disorder) 1095 Parkinson-dementia complex of Guam (disorder) 1096 General paresis - neurosyphilis (disorder) 1097 Alzheimer's disease (disorder) 1098 Senile dementia (disorder) 1099 Presenile dementia (disorder) 1100 Dialysis dementia (disorder) 1101 Impaired cognition (finding) 1102 Behavioral disturbance co-occurrent and due to late onset Alzheimer dementia (disorder) 1103 Cognitive impairment co-occurrent and due to human immunodeficiency virus infection (disorder) 1104 Cognitive deficit in attention (finding) 1105 Depressed mood in Alzheimer's disease (disorder) 1106 Delusions in Alzheimer's disease (disorder) 1107 Cognitive changes due to organic disorder (finding) 1108 Early onset Alzheimer's disease with behavioral disturbance (disorder) 1109 Altered behavior in Alzheimer's disease (disorder) 1110 Dementia due to multiple sclerosis with altered behavior (disorder) 1111 Altered behavior in dementia due to Huntington chorea (disorder) 1112 Hallucinations co-occurrent and due to late onset dementia (disorder) 1113 Cognitive impairment due to toxicity of substance (disorder) 1114 Impaired executive functioning (finding) 1115 Dissociative neurological symptom disorder co-occurrent with cognitive symptoms (disorder) 1116 Cognitive impairment co-occurrent and due to primary psychotic disorder (disorder) 1117 Severe cognitive impairment (finding) 1118 Moderate cognitive impairment (finding) 1119 Memory impairment (finding) 1120 Impaired environmental interpretation syndrome (finding) 1121 Disturbance of cognitive learning (finding) 1122 Lack of thinking ability (finding) 1123 Minimal cognitive impairment (finding) 1124 Age-related cognitive decline (finding) 1125 Diabetes mellitus (disorder) 1126 Atypical diabetes mellitus (disorder) 1127 Diabetes mellitus due to pancreatic injury (disorder) 1128 Erectile dysfunction co-occurrent and due to diabetes mellitus (disorder) 1129 Acute complication co-occurrent and due to diabetes mellitus (disorder) 1130 Metabolic acidosis co-occurrent and due to diabetes mellitus (disorder) 1131 Lactic acidosis co-occurrent and due to diabetes mellitus (disorder) 1132 Alaninuria, microcephaly, dwarfism, enamel hypoplasia, diabetes mellitus syndrome (disorder) 1133 Diabetic mastopathy (disorder) 1134 Pancreatic hypoplasia, diabetes mellitus, congenital heart disease syndrome (disorder) 1135 Gingival disease co-occurrent with diabetes mellitus (disorder) 1136 Diabetes mellitus in remission (disorder) 1137 Diabetes mellitus due to genetic defect in insulin action (disorder) 1138 Diabetes mellitus due to genetic defect in beta cell function (disorder) 1139 Disorder of nervous system co-occurrent and due to diabetes mellitus (disorder) 1140 Peripheral vascular disorder co-occurrent and due to diabetes mellitus (disorder) 1141 Disorder of soft tissue co-occurrent and due to diabetes mellitus (disorder) 1142 Diabetes mellitus during pregnancy, childbirth and the puerperium (disorder) 1143 Disorder of kidney co-occurrent and due to diabetes mellitus (disorder) 1144 Houssay's syndrome (disorder) 1145 Diabetes mellitus without complication (disorder) 1146 Diabetes mellitus type 1 (disorder) 1147 Diabetes mellitus type 2 (disorder) 1148 Disorder of eye co-occurrent and due to diabetes mellitus (disorder) 1149 Secondary diabetes mellitus (disorder) 1150 Diabetes insipidus (disorder) 1151 Partial diabetes insipidus (disorder) 1152 Hypohidrosis-diabetes insipidus syndrome (disorder) 1153 Nephrogenic diabetes insipidus (disorder) 1154 Dipsogenic diabetes insipidus (disorder) 1155 Idiopathic diabetes insipidus (disorder) 1156 Diabetes mellitus AND insipidus with optic atrophy AND deafness (disorder) 1157 Neurohypophyseal diabetes insipidus (disorder) 1158 Familial diabetes insipidus (disorder) 1159 Polypharmacy (finding) 1160 Nutraceutical polypharmacy (finding) 1161 On four or more medications (finding) 1162 Patient on numerous drugs (finding) 1163 Loop diuretic overdose (disorder) 1164 Aminoglycoside (substance) 1165 Analgesic (substance) 1166 Medicinal product acting as analgesic agent (product) 1167 Substance with opioid receptor agonist mechanism of action (substance) 1168 Antiarrhythmic agent (substance) 1169 Medicinal product acting as antiarrhythmic agent (product) 1170 Quaternary ammonium compound with anticholinergic mechanism of action (substance) 1171 Vasodilator (substance) 1172 Hypotensive agent (substance) 1173 Hypotensive agent (product) 1174 Anti-psychotic agent (substance) 1175 Medicinal product acting as antipsychotic agent (product) 1176 Diuretic (substance) 1177 Medicinal product acting as diuretic (product) 1178 Loop diuretic (substance) 1179 Psychoactive substance (substance) 1180 Antidepressant (substance) 1181 Medicinal product acting as antidepressant agent (product) 1182 Anti-psychotic agent (substance) 1183 Medicinal product acting as antipsychotic agent (product) 1184 Benzodiazepine (substance) 1185 History of Falling 1186 Fall (event) 1187 Fall into water (event) 1188 Fall on soft surface (event) 1189 Fall on hard surface (event) 1190 Jump from burning structure (event) 1191 Accidental fall (event) 1192 Fall in, on, or from train (event) 1193 Engaged in falling (event) 1194 Fall on snow (event) 1195 Falls (finding) 1196 Falls caused by medication (finding) 1197 Elderly fall (finding) 1198 At risk for falls (finding) 1199 At high risk for fall (finding) 1200 At moderate risk for fall (finding) 1201 At low risk for fall (finding) 1202 Secondary Diagnosis 1203 Diagnosis (observable entity) 1204 Fetal diagnosis (observable entity) 1205 New diagnosis (observable entity) 1206 Ambulatory aid 1207 Ability to walk (observable entity) 1208 Ability to walk on uneven surface (observable entity) 1209 Ability to walk backward pulling large toy (observable entity) 1210 Ability to walk carrying large toy (observable entity) 1211 Ability to walk heel to toe (observable entity) 1212 Ability to walk on a narrow line (observable entity) 1213 Ability to start and stop walking spontaneously (observable entity) 1214 Ability to stop walking (observable entity) 1215 Ability to initiate walking (observable entity) 1216 Ability to walk down hill (observable entity) 1217 Ability to walk up hill (observable entity) 1218 Ability to walk down a slope (observable entity) 1219 Ability to walk up a slope (observable entity) 1220 Ability to walk on the flat (observable entity) 1221 Finding of walking aid use (finding) 1222 Uses two walking sticks (finding) 1223 Uses two crutches for walking (finding) 1224 Uses single crutch for walking (finding) 1225 Uses single walking stick (finding) 1226 Uses zimmer frame (finding) 1227 Tripod/quadrupod: walking (finding) 1228 Stick only for walking (finding) 1229 No aid for walking (finding) 1230 Dependence on walking stick (finding) 1231 Cane, device (physical object) 1232 Long cane (physical object) 1233 Wheelchair crutch/walking stick holder (physical object) 1234 Gait 1235 Gait normal (finding) 1236 On examination - gait normal (finding) 1237 Mental Status 1238 Orientated (finding) 1239 Oriented to person (finding) 1240 Oriented to place (finding) 1241 Oriented to time (finding) 1242 Oriented to person, time and place (finding) 1243 Disorientated (finding) 1244 On examination - disorientated (finding) 1245 Impaired environmental interpretation syndrome (finding) 1246 Spatial disorientation (finding) 1247 Disorientated in place (finding) 1248 Disorientation as to self (finding) 1249 Disorientation for person (finding) 1250 Disorientation as to people, time and place (finding) 1251 Disorientated in time (finding) 1252 Right-left disorientation (finding) 1253 Impaired cognition (finding) 1254 Behavioral disturbance co-occurrent and due to late onset Alzheimer dementia (disorder) 1255 Cognitive impairment co-occurrent and due to human immunodeficiency virus infection (disorder) 1256 Cognitive deficit in attention (finding) 1257 Depressed mood in Alzheimer's disease (disorder) 1258 Delusions in Alzheimer's disease (disorder) 1259 Cognitive changes due to organic disorder (finding) 1260 Early onset Alzheimer's disease with behavioral disturbance (disorder) 1261 Altered behavior in Alzheimer's disease (disorder) 1262 Dementia due to multiple sclerosis with altered behavior (disorder) 1263 Altered behavior in dementia due to Huntington chorea (disorder) 1264 Hallucinations co-occurrent and due to late onset dementia (disorder) 1265 Cognitive impairment due to toxicity of substance (disorder) 1266 Impaired executive functioning (finding) 1267 Dissociative neurological symptom disorder co-occurrent with cognitive symptoms (disorder) 1268 Cognitive impairment co-occurrent and due to primary psychotic disorder (disorder) 1269 Severe cognitive impairment (finding) 1270 Moderate cognitive impairment (finding) 1271 Memory impairment (finding) 1272 Impaired environmental interpretation syndrome (finding) 1273 Disturbance of cognitive learning (finding) 1274 Lack of thinking ability (finding) 1275 Minimal cognitive impairment (finding) 1276 Age-related cognitive decline (finding) 1277 At risk for cognitive impairment (finding) 1278 At risk of confusion (finding) 1279 At risk for delirium (finding) 1280 Wheelchair bound (finding) 1281 Dependent on helper pushing wheelchair (finding) 1282 Minimal help in wheelchair (finding) 1283 Independent in wheelchair (finding) 1284 Elimination, Bowel and Urine 1285 Incontinence (finding) 1286 Incontinence without sensory awareness (finding) 1287 Incontinence due to detrusor instability (finding) 1288 Neurogenic incontinence (finding) 1289 Urinary incontinence (finding) 1290 Incontinence of feces (finding) 1291 Micturition finding (finding) 1292 Abnormal urination (finding) 1293 Vesicovaginal fistula with involvement of urinary continence mechanism following termination of pregnancy procedure (disorder) 1294 Vesicovaginal fistula with involvement of urinary continence mechanism following obstetric delivery procedure (disorder) 1295 Vesicovaginal fistula with involvement of urinary continence mechanism due to and following obstructed labor (disorder) 1296 Vesicovaginal fistula with involvement of urinary continence mechanism following normal delivery (disorder) 1297 Finding of bladder control (finding) 1298 Finding of flow of urine (finding) 1299 Finding related to ability to pass urine (finding) 1300 Lower urinary tract symptoms (finding) 1301 Finding of measures of urination (finding) 1302 Finding of desire for urination (finding) 1303 Finding of pattern of urination (finding) 1304 Dysfunctional voiding of urine (finding) 1305 Incomplete urination (finding) 1306 On examination - micturition reflex (finding) 1307 Control of micturition normal (finding) 1308 Normal micturition (finding) 1309 Micturition feature (observable entity) 1310 Urinary elimination status (observable entity) 1311 Ability to collect and discharge urine (observable entity) 1312 Ability to maintain urinary continence (observable entity) 1313 Measure of urination (observable entity) 1314 Characteristic of desire for urination (observable entity) 1315 Pattern of urination (observable entity) 1316 Urinary flow pattern (observable entity) 1317 Ability to pass urine (observable entity) 1318 Flow of urine (observable entity) 1319 Bowel finding (finding) 1320 Intestinal anastomosis present (finding) 1321 Bowel problem (finding) 1322 Aware of passing feces (finding) 1323 Desire for stool finding (finding) 1324 Finding of measures of defecation (finding) 1325 Finding of passage of meconium (finding) 1326 Finding of quantity of defecation (finding) 1327 Finding of frequency of defecation (finding) 1328 Finding of speed of defecation (finding) 1329 Tympanitic bowel sound (finding) 1330 Bowel assessment observations (finding) 1331 Bowel sounds continuous (finding) 1332 Bowel sounds intermittent (finding) 1333 Bowel sounds loud (finding) 1334 Bowel sounds quiet (finding) 1335 Bowel control - child (finding) 1336 Bowel sounds tinkling (finding) 1337 Bowel spasm (finding) 1338 Unaware of passing feces (finding) 1339 Constipation alternates with diarrhea (finding) 1340 Sensation as if diarrhea will start (finding) 1341 Sensation as if bowel still full (finding) 1342 Intestinal hurry (finding) 1343 Finding of large intestine (finding) 1344 Finding of small intestine (finding) 1345 Disorder of intestine (disorder) 1346 Double incontinence (finding) 1347 Urgent desire for stool (finding) 1348 Multiple diverticula of intestine (finding) 1349 Abdominal wind pain (finding) 1350 Passes stool completely (finding) 1351 Finding of defecation (finding) 1352 Defecation reflex finding (finding) 1353 Finding related to awareness of bowel function (finding) 1354 Finding of bowel action (finding) 1355 Finding of bowel continence (finding) 1356 Soiling (finding) 1357 Defecation observable (observable entity) 1358 St. Mark's incontinence score (observable entity) 1359 Time of last bowel movement (observable entity) 1360 Bowel elimination status (observable entity) 1361 Awareness of bowel function (observable entity) 1362 Feces/motions - symptoms (observable entity) 1363 Bowel action (observable entity) 1364 Requires supervision to perform wheelchair transfer (finding) 1365 Unsteady gait (finding) 1366 Visual impairment (disorder) 1367 Bilateral visual impairment (disorder) 1368 Visual impairment co-occurrent with human immunodeficiency virus infection (disorder) 1369 Drug related visual impairment (disorder) 1370 Combined visual and hearing impairment (disorder) 1371 Multiple disability visual impairment (disorder) 1372 Mild visual impairment (disorder) 1373 Moderate visual impairment (disorder) 1374 Severe visual impairment (disorder) 1375 Disorder of auditory system (disorder) 1376 Weissenbacher-Zweymuller syndrome (disorder) 1377 Cogan's syndrome (disorder) 1378 Auditory system hereditary disorder (disorder) 1379 Auditory system complication of procedure (disorder) 1380 Auditory dysfunction (disorder) 1381 Olivary heterotopia (disorder) 1382 Olive dysplasia (disorder) 1383 Hearing disorder (disorder) 1384 Disorder of ear (disorder) 1385 Non-awareness of common dangers (finding) 1386 Not aware of danger from deep water (finding) 1387 Lack of common sense about danger (finding) 1388 Not aware of danger from strangers (finding) 1389 Not aware of danger from traffic (finding) 1390 Not aware of danger from falling from heights (finding) 1391 Not aware of danger from sharp objects (finding) 1392 Not aware of danger from hot objects (finding) 1393 Lack of self awareness (finding) 1394 Poor awareness of safety at work (finding) 1395 Impulsive character (finding) 1396 Making impulsive remarks (finding) 1397 On examination - impulsive behavior (finding) 1398 Explosive personality disorder (disorder) 1399 Isolated explosive disorder (disorder) 1400 Cognitive seizure (disorder) 1401 Cognitive disorder (disorder) 1402 Neurocognitive disorder (disorder) 1403 Cognitive disorder in remission (disorder) 1404 Cognitive developmental delay (disorder) 1405 Mild cognitive disorder (disorder) 1406 Language-related cognitive disorder (disorder) 1407 Age-associated memory impairment (disorder) 1408 Cognitive dysfunction following surgical procedure (disorder) 1409 Impaired cognition (finding) 1410 Behavioral disturbance co-occurrent and due to late onset Alzheimer dementia (disorder) 1411 Cognitive impairment co-occurrent and due to human immunodeficiency virus infection (disorder) 1412 Cognitive deficit in attention (finding) 1413 Depressed mood in Alzheimer's disease (disorder) 1414 Delusions in Alzheimer's disease (disorder) 1415 Cognitive changes due to organic disorder (finding) 1416 Early onset Alzheimer's disease with behavioral disturbance (disorder) 1417 Altered behavior in Alzheimer's disease (disorder) 1418 Dementia due to multiple sclerosis with altered behavior (disorder) 1419 Altered behavior in dementia due to Huntington chorea (disorder) 1420 Hallucinations co-occurrent and due to late onset dementia (disorder) 1421 Cognitive impairment due to toxicity of substance (disorder) 1422 Impaired executive functioning (finding) 1423 Dissociative neurological symptom disorder co-occurrent with cognitive symptoms (disorder) 1424 Cognitive impairment co-occurrent and due to primary psychotic disorder (disorder) 1425 Severe cognitive impairment (finding) 1426 Moderate cognitive impairment (finding) 1427 Memory impairment (finding) 1428 Impaired environmental interpretation syndrome (finding) 1429 Disturbance of cognitive learning (finding) 1430 Lack of thinking ability (finding) 1431 Minimal cognitive impairment (finding) 1432 Age-related cognitive decline (finding) 1433 At risk for cognitive impairment (finding) 1434 At risk of confusion (finding) 1435 At risk for delirium (finding) 1436 PROCEDURES/THERAPIES/PHYSICAL OBJECTS 1437 Analgesic technique (procedure) 1438 Administration of intravenous antiarrhythmic drug (procedure) 1439 Diuretic therapy (procedure) 1440 Antidepressant therapy (procedure) 1441 Antipsychotic drug therapy (procedure) 1442 Benzodiazepine therapy (procedure) 1443 Analgesic technique (procedure) 1444 Administration of intravenous antiarrhythmic drug (procedure) 1445 Diuretic therapy (procedure) 1446 Antidepressant therapy (procedure) 1447 Antipsychotic drug therapy (procedure) 1448 Benzodiazepine therapy (procedure) 1449 Bedrest care (regime/therapy) 1450 Bedrest (regime/therapy) 1451 Primary bedrest stabilization of spinal fracture (procedure) 1452 Primary open reduction spinal fracture and bedrest stabilization (procedure) 1453 Revision to bedrest stabilization of spinal fracture (procedure) 1454 Primary closed reduction spinal fracture and bedrest stabilization (procedure) 1455 Revision to open reduction spinal fracture and bedrest stabilization (procedure) 1456 Revision to closed reduction spinal fracture and bedrest stabilization (procedure) 1457 Assistance with mobility (procedure) 1458 Assistance with mobility in bed (procedure) 1459 Walking aid (physical object) 1460 Stick, walking device (physical object) 1461 Crutches (physical object) 1462 Walking frame (physical object) 1463 Tripod (physical object) 1464 Cane, device (physical object) 1465 Crutch, device (physical object) 1466 Cane, device (physical object) 1467 Long cane (physical object) 1468 Walking assistive device (physical object) 1469 Walking stick/Crutches (physical object) 1470 Walker/Walking frame (physical object) 1471 Walking aid ice grip (physical object) 1472 Walking stick holder (physical object) 1473 Walking aid handgrip (physical object) 1474 Walking aid tip (physical object) 1475 Walker (physical object) 1476 Gait rehabilitation electronic walker (physical object) 1477 Walking chair, non-foldable (physical object) 1478 Walking table (physical object) 1479 Basic walker, non-foldable (physical object) 1480 Walking chair, foldable (physical object) 1481 Basic walker, foldable (physical object) 1482 Bariatric walker, non-foldable (physical object) 1483 Bariatric walker, foldable (physical object) 1484 Patient/medical device walker, home-use (physical object) 1485 Patient/medical device walker (physical object) 1486 Intravenous therapy/heparin lock 1487 Heparin lock flush syringe, single-use (physical object) 1488 Heparin lock flush syringe, reprocessed (physical object) 1489 Intravenous therapy (regime/therapy) 1490 Checking intravenous tubing for air bubbles (regime/therapy) 1491 Changing intravenous infusion line (regime/therapy) 1492 Administration of sedative (procedure) 1493 Benzodiazepine therapy (procedure) 1494 Administration of sedative via rectal route (procedure) 1495 Induction of minimal sedation (procedure) 1496 Induction of deep sedation (procedure) 1497 Induction of conscious sedation (procedure) 1498 Oral sedation (procedure) 1499 Sedation with analgesic adjunct (procedure) 1500 Inhalational sedation (procedure) 1501 Intramuscular sedation (procedure) 1502 Intravenous sedation (procedure) 1503 Induction of sedation (procedure) 1504 Premedication for anesthetic procedure (procedure) 1505 Intravenous infusion (procedure) 1506 Intravenous radionuclide therapy (procedure) 1507 Infusion of drug or medicament via intravenous route (procedure) 1508 Resuscitation using intravenous fluid (procedure) 1509 Diabetes mellitus insulin-glucose infusion in acute myocardial infarction (procedure) 1510 Continuous infusion of dextrose saline (procedure) 1511 Continuous infusion of normal saline (procedure) 1512 Intravenous blood transfusion (procedure) 1513 Intravenous blood transfusion of platelets (procedure) 1514 Insertion of pleural tube drain (procedure) 1515 Opening of chest and insertion of pleural tube drain (procedure) 1516 Insertion of drainage tube into pleural cavity using ultrasound guidance (procedure) 1517 Insertion of pleural tube using computed tomography guidance (procedure) 1518 Thoracentesis with insertion of pleural tube (procedure) 1519 Insertion of underwater seal chest drain (procedure) 1520 Tube thoracostomy with water seal (procedure) 1521 Injection of indwelling catheter (procedure) 1522 Hickman line injection (procedure) 1523 Portocath injection (procedure) 1524 Replacement of indwelling catheter of urinary bladder (procedure) 1525 Deflating indwelling urethral catheter balloon (procedure) 1526 Catheterization of bladder by indwelling suprapubic catheter (procedure) 1527 Therapeutic drainage of amniotic fluid by indwelling catheter (procedure) 1528 Insertion of tunneled indwelling catheter with cuff into pleura (procedure) 1529 Insertion of indwelling tunneled catheter with cuff by percutaneous approach using radiologic guidance (procedure) 1530 Insertion of indwelling catheter into urinary bladder (procedure) 1531 Indwelling catheter removed (situation) 1532 Indwelling catheter inserted (situation) 1533 Intermittent pneumatic compression stockings (physical object) 1534 Assistance with mobility (procedure) 1535 Assistance with mobility in bed (procedure) 1536 Self-care assistance: transfer (procedure) 1537 Able to transfer location with assistance (finding) 1538 Ambulation training (procedure) 1539 Gait training procedure (procedure) 1540 Ambulation therapy (regime/therapy) 1541 OTHER 1542 Diagnoses/Comorbidities 1543 Fluids 1544 Orders 1545 Family History 1546 Prior Bed Exits 1547 # of Nurse Calls 1548 Length of Stay 1549 Rounding Compliance 1550 Hospital Unit 1551 RISK INDICATORS 1552 Falls 1553 Pulmonary 1554 Skin 1555 Mobility Score 1556 Braden Score 1557 RISK SCORES (* = Falls, ** = EWS) 1558 Morse* 1559 Johns Hopkins (JHFRAT)* 1560 Hendrich* 1561 Humpty Dumpty* 1562 STRATIFY* 1563 MEWS** 1564 NEWS** 1565 PEWS** 1566 MEOWS** 1567 SIRS** 1568 SOFA** 1569 RISK STRATIFICATIONS (High, Medium, Low) 1570 Missing Risk Score/Risk Stratification Parameters 1571 RESPONSES (NOTIFICATIONS AND ACTIONS) 1572 RISK CONTEXT (for Patient Deterioration sub-vectors) 1573 Respiratory Distress 1574 age >= 70 1575 60 <= age <= 70 1576 prior hospitalization within 90 days 1577 COPD 1578 morbid obesity 1579 weight >= 250 lbs & gender = F 1580 weight >= 300 lbs & gender = M 1581 abdominal aortic aneurysm surgery 1582 pneumonia 1583 albumin < 40 1584 blood urea nitrogen > 40 1585 respiratory rate > 30 1586 respiratory rate < 10 1587 spo2 < 95 1588 peripheral edema 1589 current opioids 1590 pulmonary consult 1591 blood transfusion 1592 decreased loc 1593 restlessness 1594 Sepsis 1595 Acute Kidney Injury 1596 Hemorrhage 1597 Congestive Heart Failure 1598 Respiratory Distress
In Table 11, the bolded entries in the data elements column are headings or data elements categories and the data elements listed beneath the bolded heading line are the data elements within the bolded category.

(135) According to this disclosure, phrases of the form “at least one of A and B” and “at least one of the following: A and B” and similar such phrases, mean “A, or B, or both A and B.” Phrases of the form “at least one of A or B” and “at least one of the following: A or B” and similar such phrases, also mean “A, or B, or both A and B.”

(136) Although certain illustrative embodiments have been described in detail above, many embodiments, variations and modifications are possible that are still within the scope and spirit of this disclosure as described herein and as defined in the following claims.